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Background: The literature suggests that although the idea of using evidence to 
inform policy making has come into favour, actualising this idea in practice is 
complex. Within the framework of these debates this dissertation focuses on the 
uptake of findings from research into policy making for the use of magnesium 
sulphate in the treatment of eclampsia and pre-eclampsia within South Africa. 
Despite the publication over the past decade of evidence suggesting the effectiveness 
of magnesium sulphate as a treatment for eclampsia and pre-eclampsia, eclampsia 
remains a leading cause of maternal death in South Africa and in many other low and 
middle income countries. This dissertation forms part of a larger study investigating 
the uptake of research into policy making in South Africa, Mozambique and 
Zimbabwe. 
Aim: To describe and analyse the actual and perceived utilisation of research 
information in policy making and guideline development for the use of magnesium 
sulphate in the treatment of eclampsia and pre-eclampsia. 
Methods: This qualitative study triangulated three techniques in order to understand 
research utilisation in contemporary policy making. The techniques employed were: 
policy document review, a historical overview and individual qualitative interviews 
with 15 key informants. Data generated through these methods are reflected upon in 
relation to each other and within the context of relevant scientific and intellectual 
debates. 
Findings: This study shows a positive example of research utilisation in policy 
making and guideline development. In the late 1990's in South Africa, prompted by 
factors such as the recent political change, policies and management guidelines were 
being developed for maternal health. Simultaneously evidence from randomized 
controlled trials and systematic reviews showed the effectiveness of magnesium 
sulphate for the treatment of eclampsia and pre-eclampsia. Policies developed during 
this period make explicit reference to the use of the most recent published evidence. 
The uptake of this evidence into national policy development is likely explained by 
V 
the complex interaction of a range of factors: the existence of a previously established 
evidence-based culture among obstetricians; the movement of "networked" 
individuals immersed in that culture into key positions in the new government; the 
involvement ofresearchers in policy development; and the willingness of individuals 
and groups to lobby and advocate both for the development of policy and for the use 
of evidence in that policy. 
Discussion and Conclusions: The findings highlight the role played by researchers in 
developing evidence based policies and guidelines. It also points to the complexity of 
the relationship between knowledge production and the utilisation of research in 
policy. It suggests that while researchers may not be in control of factors such as 
political change, they are presented with windows of opportunity that may allow them 
to affect policy change. Their capacity to affect such change can be enhanced through 
collective action when researchers are organised through academic networks. 
Keywords: policy making, research utilization, evidence, reproductive health 




1.1. Using research to inform health care policy 
A shift is taking place within debates on what the basis of health care decision making 
ought to be. Increasingly, the importance of basing health care decision making at 
both a clinical and a policy level on the outcome of sound research studies is being 
recognised (Davies, et al., 1999; Garner, et al., 1998; Hanney et al., 2003; Lavis et al., 
2004; Macintyre et al., 2001; Swartz, et al., 2004; Volmink et al., 2004 ). This 
acknowledgement of the place ofresearch information in decision making is fairly 
recent. Davies and Nutley (1999) suggest that this shift has been encouraged by the 
growth of evidence based medicine. Proponents of this approach suggest that policy 
decisions about resource allocation (Gamer et al., 1998; Swartz, 2004) ought to be 
made on the basis of"what works" (Davies et al., 1999; Macintyre et al., 2001). In 
tum they believe that "what works" can be determined on the basis of sound research 
evidence from the evaluation of health care interventions, particularly evidence from 
systematic reviews of randomised controlled trials (Gamer, et al., 1998; Lavis et al., 
2004; Volmink et al., 2004). It is argued that decisions made on the basis ofresearch 
evidence can be not only cost saving (Gamer et al., 1998), but also life saving 
(Volmink et al., 2004). Supporting this change in attitude is the increasing growth 
and availability of a pool of evidence to base decisions upon (Lavis et al., 2004; 
Volmink et al., 2004). Yet none of these factors have led to the automatic uptake of 
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research into policy making (Black, 2001; Hanney et al., 2003; Innvaer, et al., 2002; 
Lavis et al., 2002). 
The relationship between knowledge production (evidence from research) and 
knowledge utilisation ( evidence used in policy making, programme implementation, 
programme design, etc.) is complex (Aaserud et al., 2005; Kothari, 2005; Lavis et al., 
2002, 2003; Swartz, 2004). Furthermore, it is suggested that there are many 
impediments to the use ofresearch in policy making (Black, 2001; Innvaer et al., 
2002; Walt, Chap. 9, 1994). Thus beyond asking, "what works" in terms of health 
care interventions, the process of knowledge utilisation in health care policy making 
has in itself, become an area of study (Hanney et al., 2003; Lavis, 2003). Hanney et 
al. (2003, p. 2) contextualise the need to understand the process of research utilisation 
within the "growing demands for accountability for research expenditure". 
Paraphrasing from Shulock (1999), Lavis et al. (2002, p. 125) ask of the production of 
research "if it is not used, why do we produce so much of it?" 
These questions become particularly pertinent in low and middle income countries 
which face a scarcity ofresources coupled with a high disease burden. For many of 
the health problems contributing to the burden of disease in these countries, research 
has identified effective and affordable interventions. Often, however, these 
interventions are not implemented or are discarded in favour of unproven 
interventions. While the relationship between research and policy making is 
extensively studied in high income countries, very few studies have explored this 
complex phenomenon within low and middle income countries (Innvaer et al., 2002). 
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1.2. A three country case study of research utilisation in policy 
making 
This study addresses itself to the question of how research information can be better 
utilised in policy making. It is set in South Africa, a middle income country. This 
piece of research is a sub-study within a larger qualitative study entitled: 
Barriers and facilitators affecting the implementation of findings from 
randomized controlled trials into health care policy and practice in low and 
middle-income countries: the implications for scaling up (Alliance for Health 
Policy and Systems Research [AHPSR] proposal, Appendix 1) 
In this main study, collaborating researchers aim to "improve the uptake, by policy 
makers in low- and middle-income countries, of findings from randomized controlled 
trials by describing the barriers and facilitators to the use of such findings" (AHPSR 
proposal). In order to do so, the research focuses on policy making in two case areas, 
namely policies for the use of magnesium sulphate in the treatment of eclampsia and 
pre-eclampsia and policies on the use of bednets and indoor residual household 
spraying for the control of malaria. The main study will compare data collected in 
South Africa, Zimbabwe and Mozambique. It focuses on the perceptions of policy 
makers and researchers in these two case areas around the uptake of findings into 
policy. 
The sub-study will limit itself to a focus on the uptake of findings from research into 
the policy making and guideline development for the use of magnesium sulphate in 
the treatment of eclampsia and pre-eclampsia within South Africa. The main 
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scientific work ofthis sub-study will be the analysis of qualitative data collected 
between 2004 and 2006 as part of the main study. 
1.3. Background to this case study 
1.3.1. The problem 
Hypertension remains a leading cause of maternal death in South Africa. In 1998 
hypertension in pregnancy was reported as the highest primary obstetric cause of 
maternal death (23.2%) in South Africa (NCCEMD, 1999). Within this, eclampsia 
(Box 1) accounted for the highest percentage (59%) of the deaths due to hypertensive 
disorders of pregnancy (NCCEMD, 1999). A subsequent enquiry into maternal death 
(NCCEMD, 2002) reported complications of hypertension as remaining the highest 
(20.7%) direct primary obstetric cause of maternal death. Again, eclampsia accounted 
for the highest percentage of deaths (57 %) within the hypertensive disorders. 
Hypertension-related deaths were surpassed only by non-pregnancy related infections 
(31.4%) amongst which death from AIDS related illness is included (NCCEMD, 
2002). Hence hypertension remains the leading direct primary obstetric cause of 
maternal mortality (Pattinson, 2004). 
4 
Eclampsia is the occurrence of a convulsion (fit) in association with pre-eclampsia. 
Pre-eclampsia has been defined as "a multisystem disorder [ of pregnancy] that is 
usually associated with raised blood pressure and proteinuria but, when severe, can 
involve the woman's liver, kidneys, clotting system, or brain. The placenta is also 
often involved, with an increased risk of poor growth and early delivery for the baby 
Duley, L, Henderson-Smart, DJ: Magnesium sulphate versus diazepam for eclampsia. 
The Cochrane Database of Systematic Reviews 2003, Issue 3. Art. No.: CD000127. 
DOI: 10.1002/14651858.CD000127.) 
Box 1: A definition of eclampsia and pre-eclampsia 
1.3.2. A potential treatment solution 
Since Egyptian times, but more so since the tum of the 201h century, a number of 
different treatments for eclampsia and pre-eclampsia have been used (Duley, 2005). 
Included in these were both non-obstetric methods such as keeping the woman calm 
in a darkened room, and the use of drugs such as Magnesium Sulphate, Diazepam, the 
'Menom regime' oflytic cocktail (combination of 3 drugs, including chlorpromazine), 
Heminevrin and Phenytoin. Until recently the evidence for the effectiveness of any of 
these treatments has been weak (Duley, 2005; ETCG, 1995; MTCG, 2002; Sheth & 
Chalmers, 2002). Over the past decade, this situation has changed. Two large 
multinational randomised controlled trials showed the effectiveness of the use of 
magnesium sulphate for the treatment of eclampsia and pre-eclampsia (ETCG, 1995; 
MTCG, 2002). Included in this research was data collected at sites within South 
Africa, by South African collaborators who also published their opinions locally 
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(SAMTCG, 2003). The evidence from these two trials was further supported by three 
systematic reviews (Duley, et al., 2003a, 2003b, 2003c). Hence a potential treatment 
solution1 to this high eclampsia related maternal mortality in South Africa is available. 
But experience from elsewhere suggests that this evidence has not necessarily been 
translated into policy and/or practice (Mohamed et al., 1998; Sheth & Chalmers, 
2002). Using the example of magnesium sulphate, Garner et al. (1998) argue that 
while in 1995 a large trial showed that this drug was the most effective treatment for 
eclampsia, other less effective therapies were still being used in obstetric practices in 
one third of the world. This study explores, in terms of policy guiding obstetric care, 
how evidence from these trials (and potentially other research studies) has been taken 
up in South Africa. 
1.3.3. The policy making context 
South Africa's health system has been dramatically and negatively impacted upon by 
its apartheid past (Baldwin-Ragaven et al., 1999). Maternal health services as with 
other health services have suffered as a consequence (Penn-Kekana & Blaauw, 2002). 
Prior to the change of government in 1994, there was no single national maternal 
health policy, let alone coordinated treatment protocols. Instead, each institution 
decided upon its own protocols. Maternity services attached to tertiary institutions 
often adopted these protocols. Doctors and nurses enrolled at these various tertiary 
institutions would be taught according to these individualised protocols. This led to a 
lack of uniformity, with every institution believing that its treatment option was 
supenor. 
1 This study acknowledges the impact of the health system on treatment success, but it is not the focus 
here. 
6 
Since the first democratic elections in 1994, there have been attempts at reforming the 
inequitable health system of South Africa's apartheid past into one more suited to the 
health needs of all South African citizens (Benatar, 1997; Davenport & Saunders, 
2000; Head, 1996). One of the areas impacted upon by these reform attempts has 
been maternal health (Box 2). 
• South African Constitution guarantees equality for women, right to health care including 
reproductive heath care, right to dignity. 
• 1994 Free health care for pregnant women and children under the age of 6 
• 1996 Choice on Termination of Pregnancy Act 
• 1996 Maternal Child and Women's Health Policy Committee- MCWH organised in its own 
directorate with a National Director. 
• 1997 All maternal deaths made notifiable & National Committee on Confidential Enquiries 
into Maternal Deaths appointed. 
• 1999 Saving Mothers. Report on the Confidential Enquiries into Maternal Deaths 1998 
• 1999 National Maternity Case Record 
• Saving Babies. A Perinatal Care Survey of South Africa. 
• 2001 Guidelines for Maternity Care in South Africa, Saving Mothers Policy & Management 
Guidelines 
Penn-Kekana, L. & Blaauw, D. (2002) A rapid appraisal of maternal health services in South 
Africa: A Health Systems Approach. Johannesburg: Centre for Health Policy, University of 
Witwatersrand. 
Box 2: Legislative and Policy Milestones since 1994 impacting on women's health 
In their rapid appraisal of maternal health services in South Africa, Penn-Kekana and 
Blaauw (2002) point to the recognition by national government of child and women's 
as a priority since 1994. In this regard there has been the organisation of maternal, 
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child and women's health into a national directorate, which led the attempts at 
transformation. 
During this period of transformation the National Department of Health recognised 
that the rate of maternal mortality was too high and that a significant number of these 
deaths were preventable (NCCEMD, 2001). Furthermore it was felt that clearly spelt 
out treatment regimes were a key strategy in preventing maternal death and reducing 
the maternal mortality ratio (Ibid.). Within this context national policies were 
regarded as broad statements of problems and goals (Ibid.). National guidelines in 
turn followed on from these statements by offering more detail as to treatment 
options. These then could be adapted to contextually specific detailed protocols for 
use at an institutional level. Our interest in this study has been in the national 
'directives' on the treatment of eclampsia and pre-eclampsia, not just the broad 
statements. These directives were spelt out in the following documents published by 
the National Department of Health: 
• National Maternity Care Guidelines Committee (NMCGC) of the Department 
of Health, Guidelines for Maternity Care in South Africa: A manual for 
clinics, community health centres and district hospitals, (2000 & 2002) 
• NCCEMD, Saving Mothers: Policy and Management Guidelines for 
Common Causes of Maternal Deaths, (2001) 
• NCCEMD, Saving Mothers: Second Report on Confidential Enquiries 
into Maternal Deaths in South Africa, 1999-2001, (2002) 
In effect, these guidelines are the instruments through which national policy is given 
expression. Since it is these guidelines that suggest treatment options rather than the 
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broad policy statements, these documents were most likely to offer insight into 
utilisation of research evidence on treating eclampsia and pre-eclampsia. 
1.3.4. An opportunity for research exploration 
From the perspective of this study, what has occurred over the past decade is a 
contemporary convergence between the production of evidence at an international 
level and the development of policy and guidelines within the area of maternal health 
at a national level. This has opened up the opportunity to add to the empirical 
understanding of the relationship between evidence and policy making. It has allowed 
for a qualitative study with actors for whom the experience of engaging with 
knowledge production and policy making is still recent. 
1.3.5. Building on previous research 
A systematic review (Innvaer et al., 2002) of studies focusing on health policy-
makers' perceptions of their use of evidence has been conducted (Box 3). Twenty-
four studies met the inclusion criteria for the review. Of these, only four were 
conducted in developing countries. This study attempts to increase the body of 
empirical data from developing countries. 
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Facilitators to research utilisation Barriers to research utilisation 
• Personal contact between researchers and • Absence of personal contact between 
policy makers researchers and policy-makers 
• Timeliness and relevance of the research • Lack of timeliness or relevance of research 
• Research that included a summary with clear • Mutual mistrust, including perceived political 
recommendations naivety of policy-makers 
• Good quality research • Power and budget struggles 
• Research that confirmed current policy or • Poor quality of research 
endorsed self-interest • Political instability or high turnover of policy-
• Community pressure or client demand for making 
research 
• Research that included effectiveness data 
Innvaer, S., Vist G., Trommald M., & Oxman A. (2002). Health policy-makers' perceptions of 
their use of evidence: a systematic review. J Health Serv Res Policy. Oct; 7( 4):239-44. 
Box 3: Summary from Innvaer et al., 2002 
In response to concerns by collaborators in the Magpie Trial (MTCG, 2002), a 
previous study has looked specifically at the barriers and facilitators to the translation 
ofresults from this trial into "appropriate policies and actions" (Aaserud et al., 2005). 
The most frequent barrier cited by respondents in this study was lack of support from 
policy makers (Ibid), suggesting that more work needs to be done in order to enhance 
the link between researchers and policy makers. This sub-study attempts to move 
beyond a description of barriers and facilitators to providing more of a thick 
description, from the South African context, of the processes involved in the 
translation of evidence into national policy and guidelines. It also attempts a deeper 
analysis through the utilisation of theoretical frameworks drawn from the literature. 
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1.4. Scope of this study 
1.4.1. Aim 
This study aims to describe and analyse the actual and perceived utilisation of 
research information, in particular findings from randomised controlled trials, in 
policy making and guideline development for the use of Magnesium Sulphate in the 
treatment ofEclampsia and Pre-Eclampsia in South Africa. 
1.4.2. Objectives 
This study attempts to reach this aim through fulfilling the following objectives: 
• To understand how evidence for the treatment of eclampsia and pre-eclampsia has 
been utilised ( or not) within the current national policies and guidelines. 
• To understand the influences shaping the relationship between research and policy 
making for the treatment of eclampsia and pre-eclampsia in South Africa, from the 
perspective of the respondents and historically. 
• To understand and situate these findings within the related intellectual and scientific 
debates. 
• To develop out of the analysis, a conceptual model explaining the relationship 
between research and policy making as emerging from this data set. In other words 
to develop a theoretical model of this relationship based on the empirical data for 
this sub-study (Kothari et al., 2005). 
11 
Note: The importance of issues around policy implementation such as drug 
availability and accessibility, and health systems challenges (Parkhurst, et al., 2005) 
are acknowledged. The issue of implementation however, is beyond the focus of 
this study, which only considered policy and guideline development. 
1.5. Structure of the dissertation 
This dissertation is divided into four chapters: an introduction, a literature review, a 
description of the methods employed and an overview and discussion of the findings. 
The literature review starts off with a summary of selected theoretical and analytical 
approaches to understanding research utilisation. These have helped shape the 
student's understanding of the processes under investigation. The chapter then moves 
to explain some of the issues raised in the literature, which are pertinent to 
understanding research utilisation in policy making within developing country 
contexts. The recent evidence on the treatment of eclampsia and pre-eclampsia has 
been produced within the context of the Evidence Based Medicine paradigm. 
Furthermore, Davies and Nutley (1999) suggest that the growth in this approach has 
encouraged a shift in thinking as to what health care decisions should be based upon. 
This therefore warrants an explanation of how Evidence Based Medicine is defined 
and what some of the critiques to this approach are. From there the chapter moves on 
to describe some issues related specifically to the uptake of evidence-based practice in 
obstetrics. 
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The methodology chapter describes the qualitative approach taken. It argues for the 
appropriateness of this particular approach. It then describes the techniques employed 
and the resulting data set, which this generated. The chapter describes how this data 
was analysed. Some attention is also given to reflexivity. 
The results chapter starts with a brief document review of the use of evidence in 
recent policies and guidelines. It then presents a summary of the findings, which 
emerged from the analysis of the interview and historical data. These findings are 
discussed in the context of the literature and the methods used, bearing in mind the 




2. Literature Review 
A note on how the literature was sourced: 
Throughout the main study the investigators have been collecting and sharing relevant 
grey and published literature. The literature review presented in this study built upon 
that process through further searching. Both purposive and snowballing approaches 
to identifying appropriate literature were used. Electronic databases were purposively 
searched using specified terms. Cross referencing against the literature sourced 
through this strategy then yielded a snowball of further useful references (Greenhalgh 
et al., 2005). Thus, the primary search strategy combined electronic database searches 
using specified terms, with the deliberate sourcing ofreferences cited in the literature 
in hand. The electronic search was conducted using the internet and electronic 
databases available at the Medical Research Council and the University of Cape Town 
library. This search included a combination of the terms: research information, 
research utilisation, research evidence, policy making, magnesium sulphate, 
eclampsia, pre-eclampsia, maternal health, obstetrics and gynaecology. Sourcing 
further literature through the following up of references cited in the literature in hand 
proved to be extremely valuable. It not only provided further insights into relevant 
debates, but also provided access to further literature, which may not necessarily have 
been found with a strict adherence to our original search terms. 
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Ongoing informal discussions with co-investigators and colleagues also proved to be a 
useful source for further references. The boundary for inclusion has been the extent to 
which the literature sourced has been able to enhance insight into the research 
question. The findings from this process are reported upon and important concepts 
discussed in the literature have been applied to the data analysis process. 
2.1. An overview of theoretical and analytical approaches to 
understanding research utilisation 
There have been arguments for less a theoretical and more empirical approach to 
research utilisation (Innvaer et al., 2002; Oxman et al., 2005). However theoretical 
approaches continue to influence contemporary thinking around research utilisation 
(e.g. see its use in Bowen & Zwi, 2005; Hanney et al., 2003; Kothari et al., 2005; 
Lavis et al., 2002; Lavis et al., 2003; Tomson et al., 2005). In arguing for a link 
between theoretical and empirical understanding, Lavis et al. (2003, p. 228) claim 
"Opportunities for improving how research organizations transfer knowledge can be 
found in the differences between what the research literature suggests that research 
organisations should do and what the directors of research organizations say that they 
do". 
The six theoretical models of research utilisation described by Weiss (1979) still 
influence contemporary thinking (Bowen & Zwi, 2005; Tomson, et al., 2005). She 
suggested that research utilisation in policy making can be categorised according to 
the following models: 
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Knowledge driven: this model assumes that because knowledge exists it will be 
used. 
Problem solving: this model suggests that when faced with a problem for which 
they have no answer policy makers seek out research information and thereby fill 
their knowledge gap. 
Interactive: this model suggests that information for policy making is sought from 
a variety of sources not just research and that the process of research utilisation is 
non-linear and disorderly. 
Political: in this model those who find its conclusions 'congenial and supportive' 
use research as ammunition. 
Tactical: here decision makers use research as a means of delaying taking action, 
thus they may argue that a lack of research findings on a particular issue means 
that a decision cannot be made until such finding are available. 
Enlightenment: this suggests the utilisation of research is not a singular event; 
instead decision makers over time are influenced in their thinking by the outcome 
ofresearch (Wiess, 1979; Bowen & Zwi, 2005). 
Kothari et al. (2005, p.118) state that these "conceptual models ofresearch transfer 
have been developed to try to better understand how research findings are 
disseminated, received and acted upon". They review the historical development of 
these models suggesting that these have evolved over time. This development started 
with simple diffusion models, which assumed that research findings needed only to be 
dispersed for policy makers to take them up. This shifted to models which focused on 
how the findings were disseminated without considering the receptivity of those 
receiving them. Kothari et al. suggest that more recent models of research transfer 
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have been based on the idea that researchers and policy makers are 'two-
communities' who need to interact with each other in order for research findings to be 
utilised. 
The prominence of the 'two-communities' theory in contemporary thinking is pointed 
to elsewhere in the literature (Innvaer et al., 2002; Lavis et al., 2002). Lavis et al., 
(2002), refer to the 'two communities' metaphor as an interaction model and suggest 
that it has replaced earlier models. However, whether or not this model is any more 
helpful is still uncertain. Lavis et al. (2002, p. 145) claim: 
"Our exploratory study suggests that interaction between these "two-
communities" does influence the use of research by policy makers, although 
from the research unit directors' comments it appears that many efforts at 
interaction yield no tangible impact." 
The basis of this model is that researchers and policy makers come from two different 
perspectives of understanding and that in order for research to be utilised they need to 
be brought closer in understanding. In other words they need to start sharing 
perspectives. While Innvaer et al. (2002) recognise the value of bringing these 'two-
communities' closer to each other, they also question whether a closer relationship 
between researchers and policy makers may lead to policy makers having an undue 
influence over the research, therefore increasing the possibility of bias and reducing 
the capacity for "scientific objectivity". 
Innvaer et al. (2002) argue that next to the dominance of the two communities thesis 
as a theoretical perspective, the literature is also largely concerned with explaining the 
concept ofresearch "use". In understanding the "how" in research utilisation, three 
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types of research use are defined: instrumental use, conceptual use and symbolic use 
(Hanney et al., 2003; Innvaer et al., 2002; Lavis et al., 2003). Instrumental use 
implies direct use of the findings to solve a problem. Conceptual use refers to policy 
makers becoming enlightened by the research in a generalised way, but not in a way 
that can be directly measured. Symbolic use is linked to the political and tactical 
models ofresearch referred to earlier, where a policy maker uses the research to 
justify prior positions, actions and inactions. For researchers trying to understand 
empirically how research has been used or is being used, measuring and reporting on 
conceptual and symbolic use is difficult because it can be so indirect. 
As evidence of the complexity of research utilisation, the literature points to the fact 
that research can be used at different stages (Bowen & Zwi, 2005; Lavis et al., 2002) 
within the policy making process and that it can be used in different ways within this 
process (Innvaer et al., 2002; Lavis et al., 2003). Drawing from the field of political 
science, Lavis et al. (2002, p.133) explain that research can be utilised in the 
"prioritisation, policy development and policy-implementation stages of the policy 
making process". Similarly Bowen and Zwi (2005) describe research utilisation in 
three stages: sourcing evidence, using evidence and implementing evidence. They 
suggest that at stage one the policy makers adopt the evidence, at stage two they adapt 
it and at stage three they act on it. 
The literature points to what may seem obvious; that research information is not the 
only influence on policy and decision making (Court & Maxwell, 2005; Lavis et al., 
2002; Swartz, et al., 2004; Walt, 1994; Young, 2005). Yet as Bowen and Zwi (2005, 
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p. 0601) suggest, researchers may not take account of the broader context. They 
argue that: 
"The social and political context and the many forces at work in the policy 
environment provide challenges to integrating evidence into policy and 
practice. Researchers often do not see or recognize these factors". 
In a framework developed for understanding research utilisation in developing 
countries, (Court & Maxwell 2005, Young 2005) it is therefore suggested that it is not 
simply the credibility of the evidence, which is important, but also: 
• the capacity of the political context to absorb the research findings, 
• the links established between researchers, policy makers and other stakeholders, 
• and external influences such as international factors or economic and cultural 
influences (Ibid). 
In order to understand the place of research utilisation in policy making, we need 
therefore also to understand the broader policy making processes and to understand 
how shifts in policy making come about. In this regard Lavis et al. (2002, p. 141) (as 
reading from Goldstein & Keohane, 1993; Hall, 1993, 1996; Heclo, 1974; 
Weatherford & Mayhew, 1995) have applied a political science framework for 
distinguishing "three general categories of influence on the policymaking process" 
They refer to the influences as: 
Ideas: - research, values, etc. 
Interests: - people with a vested interest in the policy, those who will benefit or 
be harmed by the policy 
Institutions: - policy legacies and characteristics of the policy 
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During the course of our interaction with John Lavis (Lavis et al., 2002), he 
introduced a fourth category, which he and colleagues have also been working with, 
namely 'events'. Events are extraordinary occurrences such as a war, a devastating 
flood, a sudden rise in disease numbers or a dramatic change in government 
administration etc. The occurrences by their extra ordinary nature may influence 
opinions and attitudes and they may also open and close opportunities for change. For 
example, a flood may change attitudes toward housing, which may create the 
opportunity for policy in this area. Using this framework, research is but one 
component of one of the key influences, namely ideas, on policy making. The 
framework provides a useful lens through which to retrospectively assess the weight 
of the influence of research in policy making at a particular moment in time, as 
compared with all of the other influences operating at the same time. 
Another useful analytical framework is that developed by Kingdon (1995) and also 
utilised in health policy analysis by Ogden et al. (2003). Similar to the political 
science framework referred to above, this framework was not developed for the 
analysis of research utilisation specifically, but for understanding how issues enter the 
policy agenda. Kingdon (1995, 2001) suggests that running through all major 
organisations such as governments are three streams: - the problem stream, the policy 
stream and the stream of politics. These streams he suggests are largely unrelated to 
each other. So people in the problem stream concentrate on what they believe are the 
priority problems, people in the policy stream concentrate on generating solutions, but 
these may not immediately relate to the problems being dealt with in the problem 
stream. In the political stream are political events such as changes in administration. 
The same author claims: 
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"these streams develop, all independent of one another. The proposals are 
generated whether or not they are solving a given problem, the problems are 
recognized whether or not there is a solution, and political events have their 
own dynamics". (p.332) 
However, change at a policy level can occur when advocates take advantage of the 
opportunity to join these three streams together. This he calls a 'policy window', 
when either the problem is so great or there is a change in the political stream and 
advocates have the chance to jump in and push for their proposals to get on to the 
policy agenda. 
Ogden et al. (2003) have applied Kingdon's framework to understanding changes in 
international tuberculosis control policy. They identified lone health workers working 
on the problem of tuberculosis, strong networks pushing for a solution and the 
window of opportunity, which opened up as a result of the resurgence of the disease 
in New York, which was then taken advantage ofby strong advocates. Although this 
framework was not developed with research utilisation in mind, this metaphor of 
streams and windows of opportunity is useful in trying to understand what evidence 
was available (policy stream), what windows of opportunity existed for pushing this 
evidence into policy and whether or not these opportunities were taken advantage of, 
and who the advocates for the use of the evidence were. This framework allows for 
the exploration of research utilisation as a dynamic moment in policy making. Linear 
models suggest that evidence is generated, is promoted and either gets used or not 
used. In contrast this framework suggests that this process is not as clear-cut as it 
seems. It suggests that there are moments when it is more opportune to push evidence 
onto the policy making agenda than others. Analytically this allows for an 
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exploration of the dynamics at play around those moments, and how advocates were 
either successful in taking advantage of them or missed the opportunity. 
In the analysis and discussion of the findings, I attempt to balance looking at the data 
with a fresh eye while bearing in mind the theoretical approaches suggested 
previously. The discussion therefore attempts to show the place of the lessons from 
this case study within this broader literature. 
2.2. Issues in research utilisation in policy making for developing 
countries 
According to Gamer et al. (1998, p.531) "Developing countries have limited 
resources so it is particularly important to invest in health care that works". While 
research utilisation in developing countries is not as well understood as it is for 
developed countries, there is certainly a growing interest and subsequently a growing 
literature in this area (Court & Maxwell, 2005). Thinking in this field can be dated 
back by at least a decade (e.g. Walt, 1994), if not further. Since this study is being 
conducted in a developing country setting, it was important to explore this growing 
literature. Translating research findings into policy in these settings is generally 
thought to be complex (Swartz, et al., 2004) and difficult (Walt, 1994). Walt (1994) 
described impediments here including political factors, difficulties with interpreting 
the findings, differing interpretations of the potential risk implied by the study, 
ideological influences on policy makers, perceptions of the usefulness of the findings 
and the timing and communication of the studies. Drawing from their work in 
Khayelitsha, Cape Town, Swartz et al. (2004) have suggested that decisions are often 
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politically motivated, that researchers need to take cognisance of the timeliness of 
their findings in relation to policy making and of the systems and developments in the 
real world. Furthermore, they suggest that research utilisation can be influenced by 
the priorities and values of its funders. 
Few of these factors however seem particularly unique to developing country settings. 
For example, although this literature tends to emphasise the role of the political 
context, the weight of this factor here does not seem to be any different to that 
experienced in developed country settings. One distinct difference, though, is in the 
(resource) capacity for researchers based in developing countries to conduct local 
research and possibly in the capacity of policy makers to interpret and apply it. This 
indeed may add complications around interpretation and a sense of applicability. 
2.3. What is evidence based medicine? 
Thus far this review has addressed research utilisation in a very general sense. Within 
evidence based medicine, the methodological rigour of well conducted randomised 
controlled trials is perceived by many as the gold standard for generating evidence of 
the effectiveness of health interventions, although it is acknowledged that trials cannot 
answer all research questions and may not be feasible in certain circumstances 
(Davies & Nutley, 1999). However, since this study largely concerns itself with the 
uptake of evidence from two large randomised controlled trials, it is important to 
briefly discuss evidence based medicine as this is the paradigm (Albers, 2001) within 
which these trials have been conducted. The following quote well describes what 
evidence based medicine is and how it fits within the context of policy making: 
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"Evidence based medicine is the conscientious, explicit and judicious use of 
current best evidence in making decisions about the care of individual patients. 
The most reliable evidence should be used in combination with individual 
clinical expertise, including effective and efficient diagnosis, appropriate 
judgement for individual patient management, and identification and 
interpretation of patient's behaviours and needs. 
Reliable evidence is also essential for the healthcare system in order to 
improve healthcare quality and to support the most efficient use of limited 
resources. Decision makers in health care need high-quality scientific 
evidence to support clinical and health policy choices. This ensures that 
resources are invested in effective and appropriate strategies to promote 
personal and public health, and not wasted on ineffective, harmful or 
unnecessarily expensive interventions". (Abalos et al. , 2005) 
Evidence based medicine is seen as a paradigm shift (Albers, 2001) from opinion 
based medicine, where clinical decisions were based on the practitioners' knowledge 
of pathophysiology and their previous clinical experience, to decision making being 
based on the best available evidence. Within this paradigm, evidence is ranked 
(Davies & Nutley, 1999) on the basis of the appropriateness and soundness of the 
methods used to answer the research question. Proponents of this paradigm argue for 
its relevance to developing countries where the limited resources necessitate the 
implementation of interventions, which have been shown to be both the most effective 
and the most cost effective (Gamer et al., 1998; Lavis et al. , 2004; Volmink et al., 
2004). Although evidence based medicine has its roots in decision making for 
individual patients, it is suggested that it could be applied to implementation oflarge 
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scale (population level) interventions (Lavis et al., 2004). Hence the possibility of 
evidence based or evidence informed policy making (Ibid.) 
2.4. Critiques of evidence based medicine 
Despite the relative good favour which evidence based medicine has come to enjoy 
(Davies & Nutley, 1999; Ter Meulen & Dickenson, 2002), it has come under critique 
methodologically and philosophically (Lambert et al. , 2006; Ter Meulen & Dickenson 
2002; Victora et al., 2004,). 
Methodologically, the status given to randomised controlled trials and systematic 
reviews as the best source of evidence, has been questioned. Victora et al. (2004) 
suggest that while randomised controlled trials are rightfully the gold standard in 
clinical decision making, public health interventions would benefit from the utilisation 
of plausibility and adequacy evaluations. Green and Britten (1998) argue that 
research designs need to be appropriate to the questions they attempt to answer. They 
show the limitations of relying on experimental methods suggesting that these cannot 
answer all questions. Using qualitative designs, the authors suggest, "can broaden the 
scope of evidence based medicine" (Green & Britten, p1230, 1998) given its capacity 
to explore those questions which randomised controlled trials and systematic reviews 
cannot. 
In an introductory overview paper, Ter Meulen and Dickenson (2002) summarise 
several critiques of evidence based medicine (Various, 2002). Their questioning of 
the underlying values of evidence based medicine is built up using the following 
arguments: 
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• Evidence based medicine is based on idealised populations with little relevance 
to individual care 
• Evidence based guidelines are too abstract and formal, losing sight of the 
complexity of clinical practice 
• The range of questions which can be asked is limited by the view of randomised 
controlled trials as the 'only road to wisdom' 
• Drug trials could be unfairly advantaged in this because they lend themselves to 
study by randomised controlled trial 
• The use of cost effectiveness studies in evidence based medicine are 
questionable: 
o It lends itself to rationing in health policy decision making, and this 
could unfairly disadvantage certain sectors of the population 
o It could be used to control costs such as in managed care 
o Evidence based guidelines and criteria could act as a barrier to 
accessing certain services 
o The possibility of professional autonomy in decision making could be 
lost 
o Evidence based decision making gives too much power to managers 
and purchasers. 
Ter Muelen and Dickson (2002) question what they see as the regulatory function of 
evidence based medicine. What drives their arguments is a belief that the underlying 
value of evidence based medicine is rationing of services on the basis of what is good, 
bad and cost effective. Their view is that this rationing could result in the denial of 
services to certain people in a less powerful position (such as the aged), and this they 
question from the perspective of social justice. Largely, their critique is of evidence 
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based medicine which is linked to cost effectiveness research and which they believe 
is being used by powerful health managers. So for them the evidence may show that 
it is more cost effective to do something in a particular way, but from a social justice 
perspective they question whether or not this is fair. In my opinion, the issue of 
values lies not in evidence based medicine as a paradigm, but in the manner in which 
it is eventually applied. For me evidence based medicine can be used to make 
decisions which are fair or unfair, it really depends on who is making the decision and 
what their particular agenda is. As already discussed, research evidence is only one 
part of the complex process of decision making. 
2.5. Research Evidence and Obstetrics 
The use of evidence in the fields of obstetrics and midwifery has grown over the past 
thirty years alongside the growth of evidence based medicine (Albers, 2001; King 
2005; Rooks, 1999). In an overview of the history of evidence based obstetric care, 
King (2005) describes obstetric practice as having made a dramatic shift since the 
days when Archie Cochrane awarded obstetrics the " 'wooden spoon' for being the 
speciality that had made the worst use of randomized trials to inform its practice" 
(King, 2005, p. 9). Reflecting on his own experience as a student of obstetrics, he 
describes having to learn a set of obstetric practices by rote, taught by all- knowing 
professors who had an established dogma. Where research was used, it was selective, 
non-systematic, ignoring results from randomized controlled trials and using instead 
information derived from flawed studies. He attributes the shift from "opinion-based 
obstetrics" to the work of Iain Chalmers and his colleagues in promoting and 
cataloguing randomized control trials in obstetric care. 
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Students currently being trained are likely to have a very different experience to that 
of King (2005). The literature suggests that the teaching of evidence based medicine 
in obstetrics is encouraged both in well resourced developed country settings (Grimes, 
1995) and in poorer developing country settings (Olatunbosun & Edouard, 1997). 
This extends too to the practice and teaching of midwifery (Albers, 2001 ; Carr & 
Schott 2002; Tillet, 2005). 
Nearly ten years ago Olatunbosun and Edouard (1997, p. 173) claimed that "teaching 
evidence-based reproductive health in developing countries is presently visionary and 
idealistic". They described several challenges at the time to changing attitudes 
towards evidence based obstetrics in developing countries. Firstly, they pointed to a 
severe under funding of health and education services limiting the possibility of 
effective teaching of evidence based medicine. Secondly they suggested a 
dependence on literature from affluent countries despite these studies offering 
scientific information which may be neither relevant nor applicable to local 
reproductive health problems. In contrast they felt that data available from 
developing countries was not applied to clinical decision making. Thirdly their 
arguments suggest that medical teaching in developing countries at the time was not 
structured towards imparting the skills needed for the up take of evidence based 
medicine. They claim that while clinical epidemiology was making an impact in 
affluent countries, "conventional medical teaching in developing countries 
emphasizes biological plausibility and pathophysiological reasoning as the basis for 
clinic practice" (Olatunbosun & Edouard, 1997, p. 173). In other words reproductive 
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health workers were not being taught how to assimilate evidence into their daily 
practice. 
In response to these challenges the same authors made several suggestions for 
changing the prevailing attitude. They felt that there should be more collaboration 
between researchers in affluent and developing countries, including personnel 
exchange, collaborative research and access to bibliographic databases. Within 
specialist obstetric and gynaecology training there could be a focus on teaching 
evidence based medicine both philosophically and practically (i.e. critical appraisal). 
Evidence based guidelines developed elsewhere, could be made widely available, for 
example, through the internet. The authors felt it unlikely that researchers in 
developing countries would have the resources to initiate randomised controlled trials 
and therefore suggested adapting evidence collected elsewhere to local circumstances. 
They also suggest that some of the vehicles for distributing evidence at the time were 
unlikely to be read by busy clinicians and that this information should rather be 
marketed through journals or articles that are likely to be read. 
While valuable, the opinions expressed by Olatunbosun and Edouard (1997) need to 
be reflected upon within their historical context. At the time, introducing evidence 
based medicine into obstetric training even at a well resourced university department 
in the United States was regarded as experimental and novel (Grimes, 1995). 
Therefore an attitude of caution towards evidence based obstetrics may not have been 
unique to developing country settings. However, much has changed over the past ten 
years, particularly with regards to advances in and access to information technology. 
These days students, researchers, policy makers, even in the least resourced settings, 
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are all likely to have some access to the internet. The consequence of which is that 
they are further likely to be overwhelmed with information, much of which is unlikely 
to be evidence based or relevant to poorer settings. This suggests that contemporary 
teaching should focus on the skills of searching and sourcing literature and critically 
appraising it. This may better enable practitioners, researchers and policy makers to 
appropriately filter what they find. 
The World Health Organisation's Reproductive Health Library is one specific attempt 
at harnessing the capacity of information technology to advance evidence based 
reproductive health. Distributed (as portable electronic files) since 1997, this database 
is updated annually (Gillmezoglu et al., 2004). It is aimed at low income countries 
and contains mainly systematic reviews from the Cochrane Library, but also 
incorporates expert commentaries, guidance documents and implementation aids 
(Ibid.). 
A cluster randomised controlled trial is underway in an attempt to evaluate whether 
active dissemination of the Reproductive Health Library has had any impact on 
obstetric practice (Giilmezoglu et al., 2004). Similarly the impact of the Reproductive 
Health Library was evaluated through case studies of the practice of evidence based 
obstetrics at four hospitals in China (Qian et al., 2001). This study found that the 
obstetric practices of most practitioners were not evidence based, but that some 
hospitals were making incremental changes and modifications to their guidelines. 
Another study has examined the factors that might affect the translation of findings 
from the Magpie Trial (MTCG, 2002) and other randomised controlled trials into 
policy and actions in developing countries (Aaserud et al., 2005). Through their 
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investigations with trial collaborators and country level drug information officers, 
they found that there were barriers to the uptake of evidence from the Magpie Trial. 
They argue that these barriers were "complex, multifactoral and context specific", 
suggesting that the publication of evidence is important but insufficient in changing 
policy and practice. Thus they suggest supported advocacy, interaction between 
researchers and the adaptation of international evidence based guidelines for use at a 
local level. They conclude that a wide programme of support would be better than 
multiple one-off efforts. 
Both the studies by Qian et al. (2001) and Aaserud et al. (2005) then, found, that there 
were barriers to the uptake of evidence in practice and policy. The literature thus far 
has also suggested that evidence based policies whether in developed or developing 
country settings are necessary but difficult to actualise. This study attempts to 





3.1. The qualitative approach 
Karlberg et al. (2002, p.22) claim, "the reason for choosing a research method is the 
nature of the actual research problem". In other words, they argue that the research 
problem should determine the research method. The research problem as expressed in 
this sub-study and in the main study, is to understand the process of research 
utilisation in policy making. Specifically, the student hoped to gain this 
understanding through exploring the perceptions of policy makers and researchers 
based upon their lived experiences of engaging with this process. The experiential 
nature of this problem therefore called for a qualitative research approach. Malterud 
(2001, p.398) argues that "the aim of such [qualitative] research is to investigate the 
meaning of social phenomena as experienced by the people themselves". 
Further refining our attempts to understand this question within a qualitative 
approach, a case study methodology was chosen. This case study explores policy 
making for the treatment of eclampsia and pre-eclampsia in South Africa. Case-study 
methodology was useful in exploring this topic given the complexity of the issues 
involved. This approach involves " ... the investigation of a relatively small number of 
naturally occurring (rather than researcher-created) cases" (Hammersley, 1992, p. 
185, original italics). The selected social units (in this instance, a particular policy 
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making process) are viewed as a whole, allowing relationships and processes to be 
examined (Mitchell, 1983). In an attempt at method triangulation (Denzin 1989; 
Smaling, 1992), the study combined document analysis, key informant interviews and 
the development oftimelines of key events. All of these methods have been used in 
previous studies of the utilisation of research information in health policy (Hanney et 
al., 2003). 
The core research activity has been the collection and analysis of interviews with 
country level researchers and policy makers (Box 4). Exploring actors' own accounts 
of their experiences helped to enhance understanding of the processes, rather than 
simply the outcomes ofresearch utilisation. Karlberg et al. (2002) suggest that data is 
socially constructed in qualitative interviewing in the interaction between the 
researcher and the participant. In the sub-study, as with the main study, the 
researchers sought to interact with the respondents about their experiences. We 
sought the opportunity to clarify and understand in the moment of a thought being 
expressed through the interview, what the respondent really meant (Buskens, 1998). 
This kind of interaction and its associated potential for depth is simply not possible 
using any other research tool ( e.g. a non-interactive survey). 
The student has been involved in the main study as a member of the South African 
research team under the supervision of the primary co-supervisor. As such she has 
been involved in all aspects of the main study except the drafting of the study 
proposal. Although the data collection preceded the sectioning off of this sub-study 
as an MPH dissertation, the student was herself actively involved in the data 
collection, conducting several of the interviews on her own. 
33 
3.2. Methods and Techniques 
3.2.1. Document Review 
Copies of the National Maternity Care Guidelines and reports and recommendations 
generated from the Confidential Enquiries into Maternal Deaths in South Africa were 
obtained from the National Department of Health. All of these contemporary national 
policies and guidelines have been read and reviewed with the aim of establishing the 
extent to which research information has been used (Lavis et al. , 2002). This has been 
done through the checking of the referencing for each document, and the extent to 
which the use of research information is mentioned. Furthermore, the specific 
sections dealing with the treatment of eclampsia and pre-eclampsia have been read to 
establish whether or not the use of magnesium sulphate is recommended. 
3.2.2. Historical Overview 
The core component to the historical overview is a comprehensive timeline of the 
evolution of policy for the treatment of eclampsia and pre-eclampsia in South Africa. 
This timeline was compiled following these steps: 
1. An expert in eclampsia research provided most of the information to be 
included in the first draft. 
2. This draft was then shown to each respondent with a request for comment. 
3. During the course of the interviewing, the timeline was updated using 
respondent comments and other information emerging from the interviews. 
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4. A report by Penn-Kekana et al. (2002) was used in combination with 
examination of recent policy and guideline documents, to establish relevant 
policy related dates. 
5. Reference was made to the work of Duley (2005) in elaborating upon the 
history of the treatment of eclampsia. 
6. The interview data suggested that the Peri-natal Priorities Conference was an 
important platform for the growth of an evidence based culture and for the 
exchange of evidence on the treatment of eclampsia. Thus, bearing in mind 
what had already been discussed in the interviews, the abstract database2 of 
presentations made at this annual conference was mined so as to establish 
when influential individuals had addressed the conference and when issues 
related to policy making or eclampsia had been presented. 
7. A Pubmed search was done to establish when related studies, conducted by 
South African researchers were published. 
8. Finally, web sites for the Oxford Database3, the Cochrane Collaboration4 and 
the Department of Health in South Africa5 were consulted to corroborate and 
further extend the timeline. 
In much the same way as a transcript is regarded as a piece of data from which to 
draw, the full timeline has been regarded as a piece of data in the analysis of the 
findings. The historical overview therefore is presented through a summary of the full 
timeline, with further discussion incorporated into the presentation of the findings 
from the interview data. 
2 http://www.perinatalpriorities.co.za/ 
3 www.update-software.com/history/clibhist.htm 
4 http://www.cochrane.org/ docs/ cchronol.htm 
5 http://www.doh.gov .za/ department/subdir _maternal.html 
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3.2.3. Qualitative Interviews 
Individual qualitative interviews were conducted with 15 researchers and government 
officials (past and present). The student and the primary co-supervisor, who are both 
trained and experienced in qualitative interviewing, conducted the interviews. Of 
these interviews the student conducted twelve on her own, two were co-conducted 
with the primary co-supervisor and one was conducted by the primary co-supervisor 
on his own. 
The respondents, all based in South Africa, were purposively sampled on the 
understanding that they had been influential and/or knowledgeable in the process of 
policy making and guideline development (Box 4). They were identified mostly by 
word of mouth. Initially this was through enquiries with colleagues who were 
familiar with people working in this subject area. At each interview respondents were 
also asked to identify further respondents. There was also attention to fair dealing and 
seeking out negative cases (Mays & Pope, 2000). It was realised that many of the 
respondents came from similar academic networks and in the interviews this reflected 
as very similar opinions. Hence persons outside of these networks and who 
potentially held different views were actively sought out. 
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Profile of Participants 
Label in text Professional background Sex 
DoH 1 Midwife Female 
DoH2 Professor of Obstetrics and Gynaecology Male 
DoH3 Obstetrician and Gynaecologist Male 
DoH4 Midwife Female 
DoH5 Midwife, nursing tutor Female 
Acad 1 Professor in Obstetrics and Gynaecology Male 
Acad2 Associate Professor in Obstetrics and Gynaecology Male 
Acad3 Professor in Obstetrics and Gynaecology Male 
Acad4, Associate Professor in Obstetrics and Gynaecology Male 
Acad5 Professor in Nursing and Midwifery Female 
Acad6 Former Professor in Obstetrics and Gynaecology (semi-retired) Male 
Acad 7 Professor in Obstetrics and Gynaecology Male 
Acad 8 Professor in Obstetrics and Gynaecology Male 
Acad9 Professor in Obstetrics and Gynaecology Male 
Acad 10 Retired Professor in Obstetrics and Gynaecology Male 
Box4 
The interviews were conducted using an interview guide negotiated between the 
broader project team (Appendix 2). Some flexibility was used in the questioning as 
appropriate to the experience of individual participants. 
The latest available technology (a voice recording memory stick and a mini-disk 
recorder) was utilised in conducting the interviews. This equipment was chosen for 
its potential capacity to capture everything that was shared verbally between the 
informants and the interviewers. The sound quality of the recorded interviews has 
been excellent. Experienced dictation typists then transcribed the audio files and 
recordings verbatim. The student later checked these transcripts against the audio 
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files, and they were cleaned where necessary. This enhanced the quality of the 
transcripts since the typists were not always able to distinguish some of the more 
technical terms used by respondents. However, one typist was relied on more than the 
other, thereby encouraging his familiarity with the content and reducing the potential 
for error. The transcripts offer an accurate account of the discussion between the 
interviewers and the respondents. 
The audio file for one of the interviews had been corrupted, thus making it 
unreadable. This was established on the day after the interview. In order that this 
interview was not lost, the interview notes were immediately compiled (using the 
short hand notes taken during the interview supplemented by details from the 
interviewer's memory) and sent to the respondent for verification. 
Overall the interviews and the transcripts are of good quality and the current data set 
adequately answers the research questions. The data set does generate further 
questions, but these are outside of the scope of this study. While it is always tempting 
to collect more and more data, saturation has been reached with the current data set in 
its capacity to answer the research question. This study has been guided by a 
methodological principle of objectivity, which seeks to let the object speak without 
distorting it (Smaling, 1990, 1992). 
3.3. The qualitative data analysis 
This study utilised a very general qualitative approach to answering the question, (i.e. 
not specifically focused on one approach such as grounded theory or 
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phenomenology). Therefore the analysis also was conducted using an approach 
common to many qualitative studies (Pope et al., 2000). The student read the 
transcripts with an open mind and open heart (Smaling, 1993) while simultaneously 
bearing in mind pertinent issues that were emerging from her reading of the literature. 
She coded the latent and manifest themes emerging from the data as she went along. 
Once coded, quotes from each transcript were cut and paste into a single word 
processor document. The coding list recorded in this document grew as more and 
more interviews were analysed. Quotes from different interviews, which fell into the 
same category (i.e. spoke to the same theme) were grouped together under one coding 
heading. The student continually shared this set of coded quotes with the primary co-
supervisor as the data analysis progressed. Eventually, 149 word-processed pages of 
coded quotes were collected. This process yielded far more information than was 
actually related to the research question. Thus the student immersed herself further in 
the data, reading and re-reading the coded quotes, listening to the data for the essence 
of the answer to the research question. Out of this process a narrative account of a 
synthesis of the data is presented as the key research findings. The description of 
these findings is illustrated further by quotes drawn from the interviews. 
Qualitative data analysis can be a subjective process and therefore one of the 
measures suggested for enhancing the objectivity of this process is inter researcher 
triangulation. However, since this study was conducted as part of the requirements 
for an MPH degree, it required the student to show a strong degree of independent 
thought and analysis. Therefore the analysis was carried out singularly by her, but the 
process was reviewed by the primary co-supervisor and discussed with the second 
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supervisor. Furthermore, detailed descriptions of the process make it transparent for 
further review (Mays & Pope, 2000) and external validation. 
All findings from the qualitative analysis of the interviews have been triangulated 
against the document review and the historical overview. Together these data sources 
complement each other in addressing the research question. They also serve as a 
check against which to assess each other. The findings have been reflected upon in 
relation to the literature. In the discussion these findings are considered against the 
theoretical frameworks on knowledge translation, agenda setting and policy making 
described earlier. 
3.4. Reflexivity 
Throughout the process of this study, the student has attempted to adhere to the 
methodological principle of reflexivity (Mays & Pope, 2000). The influence of the 
researcher over the research object and subject is present constantly throughout any 
research study, whether qualitative or quantitative. However, the interactive nature of 
qualitative interviewing and the analysis process following, does present more 
opportunities for the researcher to shape the process and for the researcher to be 
shaped by the process. In this study the student was constantly vigilant of the fact that 
the research question had been generated from out of the discussions of a group of 
researchers with a strong interest in seeing the evidence from randomised controlled 
trials6 utilised in policy making. The student herself had recently completed a short 
course on evidence based medicine. As she read further literature as part of this 
6 Pragmatic Randomised Controlled Trial in Health Care (Practihc) 
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study, she too became more convinced of the appropriateness of using research 
information to inform policy. The student was thus open with respondents about the 
interests of the group posing the research question and about her own interests. In the 
beginning the student felt anxious in the interviews as the subject area is very medical 
and her background is not at all medical. However, explaining this to respondents 
enhanced the interviews because neither she nor they took for granted the possibility 
of a shared understanding of terms or processes which need not be explained. The 
student was also very aware of how the interaction between herself and the 
respondents was shaped by the fact that she is a younger woman and many of them 
were older males. Some responded to this as if the interview were a novelty, others 
responded as if they were being bothered by a pesky young girl, in fact one 
respondent referred to her as "young lady". In the analysis process the student had to 
be careful not to let her opinion of each respondent, formed during the interview, 
colour her capacity to engage fully with the transcript as a fresh piece of data to be 
approached openly. The primary way in which the relationship between the 
researcher and the researched subject and object were observed and kept in check in 
this study has been through the regular debriefing between the student and her 
primary co-supervisor. This gave her the opportunity to talk about the process and to 
manage it. 
3.5. Ethical considerations 
The main study received approval from ethics committees at the Medical Research 
Council of South Africa, the London School of Hygiene and Tropical Medicine, the 
University of Zimbabwe, Eduardo Modlane University and the World Health 
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Organisation. This sub-study received approval from the ethics committee 
chairperson at the University of Cape Town. 
In their review of the ethics of the study, the Medical Research Council was of the 
opinion that confidentiality may become a problem in a study of this nature. They felt 
that as the group ofrespondents in each content area may be limited, it might be easy 
to identify them in reporting, even if their names were not revealed. The research 
team acknowledged this potential and subsequently adjusted the informed consent 
form so as to give respondents a choice in how data from their interview would be 
used. Respondents were also verbally informed of this. 
All participants in the study have signed a consent form after being given a written 




This chapter presents a summary of the findings from the document review, the 
historical overview and the interview data. It starts with a description of how research 
evidence regarding magnesium sulphate has been utilised in contemporary national 
policies and guidelines. It then describes the key issues emerging from the analysis of 
the interview data in relation to the extended timeline (Appendix 3). A summarised 
version of this timeline (Box 5) is presented below. 
4.1. Research utilisation in contemporary maternal health policies 
and guidelines 
Since 1994 the following relevant guidelines for maternal care, including the 
management of eclampsia and pre-eclampsia, have been produced: 
• National Maternity Care Guidelines Committee (NMCGC) of the Department 
of Health, Guidelines for Maternity Care in South Africa: A manual for 
clinics, community health centres and district hospitals, (2000 & 2002) 
• NCCEMD, Saving Mothers: Policy and Management Guidelines for 
Common Causes of Maternal Deaths, (2001) 
• NCCEMD, Saving Mothers: Second Report on Confidential Enquiries 
into Maternal Deaths in South Africa, 1999-2001, (2002) 
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Although the "Saving Mothers: Second Report", is primarily as its title suggests a 
report on the Confidential Enquiry, it carries an annexure of guidelines at the end of 
each chapter, specific to the cause of maternal mortality discussed in the chapter. 
Hence it warrants discussion here. 
These documents are very different in the manner in which they reflect their use of 
research evidence. Both of the editions of the "Guidelines for Maternity Care" carry 
in their introduction a statement reading: 
"The guidelines are based on the best available evidence from published 
research, modified where necessary to suit local conditions. References are 
not given, but are available from the authors on request. Specifics of 
management and drug dosing are not cast in stone, and can be modified 
according to the experience of the reader and new evidence". (p. 8 in both 
editions) 
They also both refer to the Cochrane Library in their suggested further reading lists. 
In other words, although this statement claims the guidelines are based on evidence, it 
is left to the person reading the guidelines to verify if they so wish. In these two 
documents, the authors' use of evidence while suggested is not made explicit. In the 
guidelines themselves though, magnesium sulphate is the only drug recommended for 
the treatment of severe eclampsia, imminent eclampsia and eclampsia. A box also 
details exactly how the drug should be administered. 
The two "Saving Mothers" documents are far more explicit in their use of research 
evidence. The "Policy and Management Guidelines" states that it is "customary to 
grade the evidence, on which clinical statements are based, according to the strength 
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of such evidence" (p. 5). It then goes on to explain the grading levels, ( e.g. "Grade A 
Evidence from randomised controlled trials"). Within each guideline section full 
references are given to the study from which the specific recommendation is drawn 
and the grade of the evidence is given, for example: 
"Magnesium sulphate is the best drug to arrest and prevent further convulsions 
Grade A evidence. (The Eclampsia Collaborative Group. Lancet 1995; 
345: 1455-63)" 
At the end of each chapter the references are repeated. A different author writes each 
chapter and the style is slightly different from one to the other, but the emphasis on 
being explicit remains. However, not every single recommendation is referenced and 
graded, but no explanation is given as to why this is so or if these recommendations 
are simply based on the authors understanding of best practice. This style is repeated 
in the later "Saving Mothers" report (2002). 
4.2. "An uncertain field" reflections on research and treatment for 
eclampsia and pre-eclampsia 
4.2.1. Searching for an effective treatment for eclampsia and pre-eclampsia 
The abbreviated (Box 5) and unabbreviated (Appendix 3) timelines reflect a long 
history of attempts to find an effective treatment for eclampsia and pre-eclampsia at 
both international and national levels. Influential amongst these efforts are the 
publication of the Pritchard case series (1955 , 1967, 1975, 1984) on the use of 
MgS04, the suggestion of the use of diazepam by a group British physicians in Hong 
Kong (1968) and the shift to the use of phenytoin in the United Kingdom in the 
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1980's. South African researchers not only followed the international trends by 
introducing first magnesium sulphate, and later phenytoin into their teaching and 
practice, they were also making sense of and generating evidence at a local level. 
During the 1970's at least three articles were published in the South African Medical 
Journal addressing eclampsia and /or pre-eclampsia as a cause for maternal mortality. 
In 1980, this same journal published a review (Moodley, 1980) of the drugs 
commonly used for the treatment of hypertension in pregnancy. This trend of 
contributing to the evidence and to the debate has continued steadily since then. 
Researchers disseminated their findings through national and international journals 
and through nationally hosted events such as the annual Priorities in Perinatal Care 
Conferences. In 1986, the first paper on pre-eclampsia was presented at this 
conference and between then and 2003 at least forty-eight papers were presented on 
the subject of eclampsia and pre-eclampsia. In 1990 a South African randomised 
controlled trial of the effect of phenytoin compared with MgS04 for the treatment of 
eclampsia was published (Domisse, 1990). Respondents did not see this trial as 
having an impact beyond the institution in which it was conducted. 
4.2.2. The use of magnesium sulphate in South Africa 
Magnesium Sulphate for the treatment of eclampsia was introduced into medical 
training in South Africa long before the results of the Collaborative Eclampsia Trial 
(ETCG, 1995) were first made available. The earliest use of magnesium sulphate for 
the treatment of eclampsia in South Africa, as suggested by respondents, was during 
the 1950's (Acad 10). It was used by maternity services attached to the University of 
Cape Town but was later replaced by A vertin and then Diazepam and reintroduced 
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again in 1979. It was introduced at the University of Stellenbosch in the early to mid 
1970's by an individual who it is claimed had experience of using it in other settings7• 
Respondents from both universities suggest that they consulted studies from the 
United States that were being published in the international literature and which 
showed the effectiveness of the drug. Some suggest that even though these studies 
may not have been randomised controlled trials, at the time that was the best available 
evidence: 
"I think the one thing, in the 70s there were very few randomized trials, and a 
descriptive study was regarded as a pretty good study. So if you look at the 
article by Grant in 1975, I think it was, where 100 cases of eclampsia were 
managed. He reported on 100 cases of eclampsia managed by magnesium 
sulphate. That was a very key article. That article changed a lot of practice 
because that was the article people quoted on safety." (Acad 7 p. 21) 
Respondents suggest that there was a close link between the American academic 
obstetric fraternity and obstetricians based at local universities. A former head of 
obstetrics and gynaecology at Tygerberg Hospital (attached to University of 
Stellenbosch) was elected as a fellow of the American College of Obstetricians. He 
then hosted members of this fraternity at his institution, inviting members of other 
local obstetric and gynaecology departments to attend these lectures. Similarly, a 
former head of maternity care at Groote Schuur Hospital (attached to the University of 
Cape Town), hosted American researchers at his institution and visited their practices 
in the United States. According to the data the practice of using magnesium sulphate 
spread through medical training and as trained specialists moved to other institutions, 
so it spread there too. 
7 This is anecdotal as the person concerned was not interviewed, however it has both been suggested 
that he was introduced to it in practice in Harare and through training at the University of Cape Town. 
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Although respondents suggest that many obstetricians in South Africa were using 
magnesium sulphate before the results of the Collaborative Eclampsia Trial were 
available, this practice was certainly not unanimous: 
"I think it depended on where people studied. It's depended on what people 
read and it's depended on what people believed. And that's because there 
were convincing studies showing that either of those treatments are acceptable. 
So it was difficult for people to decide once you became used to something. It 
was difficult to start using the other side - so it was an uncertain field." (Acad 
6 p. 3) 
"The point is, until the randomised studies were set up, no one had any basis 
for pointing a finger at anyone else and saying, what you're doing is right or 
wrong." (Acad 8 p. 12) 
" R: So I think those were the two poles, and people were sometimes quite 
adamant about what was working best; people very, very strongly believed in 
their treatment. We had quite warm discussions about it because everybody 
believed that they were actually giving the best treatment. 
I: And where did those discussions take place? 
R: It took place at local congresses. It took place at inter-departmental 
meetings. It took place at the international congresses. It took place at the 
congresses of the international society for the study of hypertension in 
pregnancy. So it was at many places that ... was occurring. 
I: But when we started out, you said that currently in South Africa, it's 
generally accepted 
R: Yes. Right. 
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I: Now when did that ... how did that happen? 
R: Well, that's from after the magnesium sulphate trials. So after the 
magnesium sulphate trials there was clear evidence that it was the best. So 
people who had not been using magnesium sulphate, changed, and I know of 
many members who had changed. . . . Of course, there was suddenly a very 
good randomised controlled trial to show a better treatment." (Acad 6 p. 7) 
49 
Date Key Events in 
The evolution of policy and 11:uidelines for the treatment of eclampsia and pre-eclampsia in South Africa 
1955 First Pritchard case series published, showing effectiveness of MgS04. Updated every 10 years until 1984 
1968 British physicians in Hong Kong suggest use of diazepam 
l 970's MgS04 introduced into obstetric care at key medical faculties in South Africa 
1979 Obstetrics criticised by Archie Cochrane as being least evidence based medical speciality. 
l 980's Use of MgS04 spreads through teaching and inter-institutional contact between academics. International divisions on the choice of anti-
convulsant are reflected in the country. 
l 980's-90's South African researchers become increasingly connected to the international obstetric research community and simultaneously the local 















Although provinces and institutions have their own policies there are no national policies or guidelines 
MgS04 in widespread use in SA for treating eclampsia 
Dommisse randomised controlled trial of MgS04 vs phenytoin for eclampsia published in British Journal of Obstetrics and Gynaecology 
1990 Feb; 97 (2): 104-9. 
Pregnancy and Childbirth Group, first Cochrane Review Group to be registered 
South African researchers collaborate in Eclampsia Trial at local trial sites 
Change of government promotes new focus on maternal health and openness to academic involvement in policy making 
Collaborative Eclamosia Trial published 
Senior obstetricians in South Africa publish editorial on implications of Collaborative Eclampsia Trial 
Maternal health organised into a separate directorate within national DoH 
Academic advocacy for maternal mortality monitoring followed by the appointment of the first National Committee for Confidential 
Enquiry into Maternal Deaths (NCCEMD) 
First NCCEMD report published. Eclampsia accounts for highest percentage of the deaths due to hypertensive disorders of pregnancy, 
which is the second largest cause of maternal deaths. National policy and guidelines recommended. 
First national "Guidelines Maternity Care" published. Evidence is referred to but not referenced. 
NCCEMD publishes policy and management guidelines for common causes of maternal deaths. MgS04 recommended and use of evidence 
made explicit. 
South African researchers collaborate in Magpie Trial at local sites. South Africa is the regional trial co-ordinating centre. 
Ma1mie Trial published 
Following on from trial, MgS04 is recommended for women with moderate to severe pre-eclampsia, where it can be administered safely, 
in South African Medical Journal. 
Box 5: An abbreviated timeline of key events 
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4.3. Establishing and publicising the "evidence" 
Respondents regarded the Collaborative Eclampsia Trial (ETCG, 1995) and the 
Magpie Trial (MTCG, 2002) as the most conclusive evidence on the treatment of 
eclampsia and pre-eclampsia. Thus when they referred to the "evidence", they 
referred to the results from these trials. Furthermore it was these results, rather than 
that from earlier studies, which were contemporary during the guideline writing 
process. Hence, the trials and their results were focused on in the interviews and are 
reflected upon here. 
4.3.1. Reflections on the Collaborative Eclampsia Trial and the Magpie Trial 
Not only were both the Collaborative Eclampsia Trial and the Magpie Trial familiar to 
respondents, several of them had been involved in one or both of these studies. For 
some respondents this involvement grew out of the relationships they had formed with 
researchers at the Oxford Database of Peri-natal Trials, including Lelia Duley 
(principal investigator for both trials) during the course of sabbaticals and fellowships 
spent at this unit. Local collaborators were also actively recruited at events such as the 
Priorities in Peri-Natal Care conferences, by both local and international researchers. 
South African trial sites recruited the most number of women in both trials and local 
collaborators were widely involved overall including representation on the steering 
committees (ETCG, 1995; MTCG, 2002). 
The results of the Collaborative Eclampsia Study were well accepted according to 
respondents and, where, necessary changes to guidelines or practice were soon made: 
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" ... where guidelines were being developed, whether it was at a local level or a 
national level, I think the protocol originally from the eclampsia trial for the 
use in eclampsia, was taken up." (Acad 3 pp. 2-3) 
For them, the findings from this study ended the debate as to which anti-convulsant 
should best be used, confirming for those already convinced that magnesium sulphate 
was the most appropriate anti-convulsant, in treating eclampsia. 
" ... it didn't impact that much on the use of magnesium sulphate for eclampsia 
in our institution because we were already using it, although we were glad 
about, that it confirmed, I mean, what we believed to be the case, and that 
using that information it was much easier to convince other people." (Acad 1 
p. 15) 
One respondent however disputed the comparison being made in this trial. He felt 
that the drug dosage used for phenytoin (one of the comparative drugs) was 
inappropriate for its intended therapeutic effect. In his opinion, if this dosage had 
been different then a different trial result may have been reached and magnesium 
sulphate may not have been shown to be superior (Acad 8). 
Unlike with the Collaborative Eclampsia Study, respondents suggested that the results 
from the Magpie Trial were not so easy to apply. They argued that treating a patient 
with magnesium sulphate, particularly intravenously is labour intensive, requires 
facilities, which are not always available and can lead to complications for the mother. 
As one respondent explained, researchers locally were hoping that the trial would 
identify a subset of women who would benefit more from the prophylactic use of 
magnesium sulphate than others (Acad 3). The trial however did not do this, the 
results suggesting instead that it should be used across all degrees of pre-eclampsia. 
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However, as another respondent suggested, the "number needed to treat" figures for 
mild, moderate and severe pre-eclampsia were quite different (Acad 2). Given the 
local hesitation around interpreting the findings from this trial, he claims that the 
editorial written by the South African collaborators was "a very guarded one" (Acad 2 
p.15), in which it was suggested that the infrastructural conditions ( availability of 
drips etc.) at each local setting should be taken into consideration when implementing 
these results. 
For both trials however, respondents raised some concern about the ethics of 
conducting trials with drugs that they felt were known to be effective. At two 
institutions where researchers chose not to be involved in the Collaborative Eclampsia 
Study, they did so on the basis that they already felt the drug to be effective. One felt 
that it would be dangerous not to give magnesium sulphate to their patients (Acad 10). 
Another felt that it would be unethical to not give it to their patients during the course 
of the trial: 
"We didn' t participate because we were convinced that magnesium sulphate is 
the best, and we thought it would be unethical to expose our patients to that 
study because we've been using magnesium sulphate for so long and we were 
convinced that it is really the best." (Acad 6 p. 2) 
Similarly, ethical questions were raised in relation to the Magpie Trial. It was felt that 
it was unethical to do this trial in a developing country since there was no reason to 
think that magnesium sulphate would be any less effective in treating pre-eclampsia 
than it was in treating eclampsia and the risk for patients enrolled in a developing 
country setting was far greater than for those enrolled in well resourced settings (Acad 
8 pp. 11-12). It must be noted though, that according to the publications from the two 
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international trials (ETCG, 1995; MTCG, 2002), no conclusive evidence existed prior 
to these trials. These comments show the strength of experience in shaping opinion, 
even when the respondents are otherwise convinced of the value of using evidence. 
4.3.2. Local dissemination of the trial results 
Although respondents themselves were familiar with the results of the Collaborative 
Eclampsia Study and the Magpie Trial, they were based either at academic institutions 
or had current or previous positions within the national department of health and thus 
were more likely to have been exposed to the trial findings. When reflecting on the 
extent of the dissemination of these results more broadly, respondents differed 
significantly in their opinion as to the reach oflocal attempts at dissemination. On the 
one hand some felt that it had been well disseminated and therefore the findings were 
well known: 
"I think it was presented at a number oflocal meetings . ... the leader in South 
Africa of that trial, ... he presented it at many meetings and so it was a well 
known research in this country and in Zimbabwe." (Acad 3 pp. 2-3) 
Another respondent explained that the local dissemination was co-ordinated with the 
international dissemination in an attempt to do so with maximised effect: 
"our whole thing was the big bang, we tried to get a big bang effect, and it was 
very similar - ... Within a month or so their presentations in Oxford were 
presented throughout the country at various local meetings, and I think that 
was quite powerful. ... They, in the Eclampsia Trial and the Magpie Trial gave 
out the presentations and slides, and once the data was free then and long 
beforehand people knew on that date and at the first subsequent academic 
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meeting that was available, could be booked to, you know, to present the 
Magpie Trial, that created a vibe. People wanted to know what the final results 
were, especially, ja, the Magpie results, they especially wanted to know · ... 
then each area was going to be presented, and at the SASOG and at the 
Priorities meetings, and so on. In a short period of time everyone, well, those 
who were interested would have had clear access to the results." (Acad 7 pp. 
22-23) 
A further respondent however suggested that this dissemination only happened at the 
level of national congresses and that it did not reach clinicians in the field: 
"I: And to what extent do you think there has been a change - if at all - as a 
consequence of these two trials? 
R: I think, pause, the change has not been as widespread as expected, but 
there has been quite a bit of change. The problem has been with the 
dissemination of the information where it depended on disseminating the 
information through SASOG for instance, obstetricians, gynaecologists coming 
together. But when it comes to the general doctor out there, it hasn't been. So 
I don't even know of a forum that we had that said, maternal and child health-
care people, this is the policy. There hasn't been even a memorandum that 
went out from the provincial heads of health to say to the people on the 
ground, this is the accepted (practice)." (DoH 2 pp. 14-15) 
And yet another comment suggests that the traditional route of dissemination may 
have little impact on the majority of obstetric practice. 
"And just, sorry, the other thing is you must just remember the, that the 
majority of obstetrics is carried out by non-specialists in the country, and those 
55 
people will be only basically practicing what they learned at medical school. 
Very few of them will read The Lancet or read anything that comes out of The 
Lancet. And maybe they will read an occasional something, in the SAMJ but 
probably not that much. They'll go to CME lectures and probably very few 
will change their practice on those lectures unless there's a clear benefit for 
them to do it." (Acad 7 p. 10) 
The data therefore suggests that academics and health officials involved in policy 
making and guideline development were well informed as to the results of the two 
international trials. Respondents were less certain of the extent to which it reached 
health workers on the ground. 
4.4. The growth of a culture of evidence based obstetrics in South 
Africa 
The literature describes well the determined attempts at making the science and 
practice of obstetrics internationally more evidence based and the subsequent growth 
of evidence based obstetrics (King, 2005). The timeline also reflects key events in 
this process. It shows the close relationship between the development of the 
Cochrane Collaboration and attempts by key international obstetricians such as Iain 
Chalmers at improving and systematising the evidence base for his profession. 
Obstetrics shifted from the days when it was criticised for being the least evidence 
based medical speciality (1979), to being a forerunner in the Cochrane Collaboration 
with the Pregnancy and Childbirth Group, being the first Cochrane review group to be 
registered (1992). This trend or shift in consciousness around evidence occurred 
within academic obstetric practice in South Africa, as well. Interestingly, this 
56 
occurred despite the isolation of South African academics due to the academic boycott 
in response to apartheid. It was very clear from this set of interviews that 
respondents' conceptualisation of evidence reflected the same understanding of the 
term as promoted by proponents of evidence based medicine. The interviews suggest 
that for respondents the results from systematic reviews and randomised controlled 
trials were regarded as the highest form of research evidence. The following quote is 
reflective of how most of the respondents related to the concept of evidence: 
''No, it was purely evidence based. We really tried to be as scientific as 
possible .. . the Oxford database was used very extensively, and subsequent to 
that the Cochrane database. So we tried to stick as close as possible to 
evidence-based medicine and not sort of traditional ways and means of dealing 
with things, but really to make it, have it scientifically founded." (Acad 1 p. 2) 
What this quote reveals is a sense of evidence based practice and decision making as 
being more scientific and therefore better than the traditional practice of medicine. It 
carries with it a sense of being modem rather than old fashioned. In another quote, a 
respondent links evidence based medicine with best practice, suggestive even of a 
sense of prestige around the practice of evidence based medicine: 
"At that stage, I was a member of the society and attended all their congresses, 
and I was director of [a] perinatal mortality research unit ... So of course, you 
wanted to do the best practice. You wanted to use the best protocols. You 
wanted to do evidence based medicine." (Acad 6 p. 5) 
This conceptualisation of evidence was noted from the start of interviewing. More so, 
this conceptualisation was present and influential in the writing of the national 
policies and guidelines. Therefore, an attempt was made during the course of the 
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interviews and later in the content analysis stage, to understand from the respondents' 
perspective how the reliance on evidence in academic and in publicly funded obstetric 
practice had come about. 
The data suggests that there are several interlinking factors that contributed towards 
the creation of an evidence based culture within obstetric care. One of the factors was 
the contact and exchange between opinion leaders in international research who 
promoted evidence based practice and South African researchers. International 
researchers increasingly presented at local conferences (PPCC abstract database). 
"We actually invited Murray Inken, who was attached to the Oxford database, 
and subsequent to that Iain Chalmers, who's the editor, was invited to attend. 
So we were sort of, I think from the word go, when the Oxford database 
became available for use, we were part of it, we were aware of it, we were 
using it, and I think quite a few South Africans became involved on their 
editorial board and as editors or reviewers, or whatever." (Acad 1 pp. 2-3) 
At least three of the respondents spent time during their sabbaticals and fellowships 
working with key proponents of evidence based medicine at the Oxford Peri-natal 
Trials Unit. Two of them are particularly influential within the local obstetric 
fraternity and were within the core group of researchers who assisted in writing the 
current policies and guidelines. All of them suggest that their exposure while working 
at this unit was important in shaping their thinking around research and evidence. 
"And if you look at the proceedings of the first couple of conferences, most of 
the studies were epidemiological studies, and then you'll see, I think from the 
early 80s onwards, the move towards more and more randomized trials and 
systematic reviews were being presented. And I think it was really the 
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influence of the Oxford database of peri-natal trials which got us all thinking 
in that way." (Acad 3 pp. 8-9) 
Another factor was the existence of the annual Priorities in Peri-natal Care 
conferences and the conferences of the South African Society of Obstetrics and 
Gynaecology. As suggested by the data, these "institutions", were both open to 
receiving the new ideas around evidence based medicine and provided platforms from 
which these ideas could be promoted and shared amongst a ready audience: 
"But I think that's one very important aspect is sort of the culture ofresearch 
within a department, and the second one is exposure to events, like for 
instance, the Priorities in Peri-natal Care Conference where you gain 
knowledge and where you interact, not only with other departments in the 
country but also with overseas experts. That was very, very valuable, ja." 
(Acad 1 p. 3) 
Regular attendance at these conferences allowed for the emergence of a closely linked 
national network of researchers who promoted evidence based medicine at their own 
academic departments and nationally. An example of a national attempt is the Better 
Births Initiative (Smith et al., 2001), which has been used to promote evidence based 
care in labour. Within academic departments the data suggests this idea was 
promoted through teaching, journal clubs and largely through involvement in 
research. 
" ... so evidence, that sort of thing was really,ja, grasped with both hands. I 
think a lot of our research is clinical. So trials are our - if you want to do 
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research is our bread and butter, we are not going to really be able to do much 
on the biochemical research cause of resources and so on. So our research and 
our strengths are in clinical trials .... I don't think there's any institution out 
there O & G academic institution which doesn't use Cochrane extensively." 
(Acad 7 p. 21) 
Thus the attempts at an international level to promote evidence based medicine and 
the increased availability of evidence from trials through the Oxford Database of Peri-
natal Trials and later the Cochrane Collaboration, was met by eagerness within the 
national obstetric fraternity. 
There was one divergent voice amongst respondents. This person (Acad 8) felt that 
the use of evidence was important and to this end he taught the skills of evidence 
based medicine to his registrars. However, he also felt that there was a lack of critical 
appraisal in the use of evidence. He felt that sometimes people were more interested 
in the methods than in the relevance of question. He felt that patients needed to be 
treated individually, calling for the use of clinical judgement, not only adherence to 
the evidence. Furthermore he felt that the conducting of trials had become an 
industry. 
4.5. Policy making and guideline development for maternal 
healthcare 
There was no national policy or management guideline for maternal care until the 
publication of the Guidelines for Maternity Care in South Africa in 2000, followed by 
the Saving Mothers Policy and Management Guidelines for Common Causes of 
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Maternal Deaths in 2001. Prior to this, as respondents explained, the obstetric 
departments of the various medical universities around the country tended to draw up 
their own guidelines and protocols to be used at hospitals and maternity services 
attached to these institutions. As one respondent argued, these institutions tended to 
pursue "their own identities even in terms of protocol" (DoH 2 p.13). Students, both 
nurses and doctors, were taught practices that followed the protocol of the training 
institution where they were enrolled. This meant that there was no standardisation of 
practice across the country, with people coming from different practice backgrounds 
having to work together in one setting. This lack of national standardisation was 
compounded in some settings by having foreign doctors who had not even been 
trained using any of the protocols taught within the country. An attempt to 
standardise national practice was therefore one reason given as to why the national 
policies and guidelines were developed, but this needs some explanation in context. 
As shown in the timeline, the national policies and guidelines were published six and 
seven years after the first democratic election. The interviews suggest that the change 
in government was important to policy development in South Africa. Policy 
development is described in the data as an aspect of democratic reform, with policies 
being formulated throughout health care, not just for maternal care. The change in 
government ushered in an openness to discussions around policy between researchers 
and government, which one respondent (Acad 7) suggested was not there before. 
During this time new staff were employed into the national department of health with 
different values to those who had been there before. Respondents, who had been 
employed by the Department of Health during this phase, spoke in the interviews of 
wanting to improve health for all. One respondent suggested that the record keeping 
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under the previous government was designed to hide the health problems experienced 
in communities, but the new cadre of people being employed had experience of these 
problems and wanted to correct them: 
"So there was a need to then say it was one country, and therefore, we need to 
reform this and we need to have policies that respect everyone irrespective of 
race, colour or creed. So I think that is the one aspect. I think also the fact 
that many of the people who then came into government, came from 
underprivileged communities. So it was important and necessary to try and 
change the conditions of those communities." (DoH 2 pp. 3-4) 
This new cadre of staff, who were being appointed into key positions within the 
national department, also had long standing affiliations with the Priorities in Peri-
Natal Care Conferences and the South African Society of Obstetrics and 
Gynaecology. Given this context and these networks, respondents described how a 
small group of researchers within the country who had played a leading role within 
these same networks, were able to convince the national department and in particular 
the incoming minister of health (Dlamini-Zuma) of the need to make maternal death 
notifiable. Information gathered through this notification process would allow for an 
assessment of the leading causes of mortality through a confidential enquiry into 
maternal death. Thus in 1996 the first National Committee for the Confidential 
Enquiry into Maternal Death was appointed, chaired by Prof. Jack Moodley, a leading 
figure within the national obstetric networks (he was a member of the College of 
Medicine, the South African Society of Obstetrics and Gynaecology and attended the 
Priorities in Peri-Natal Care Conferences). Respondents describe the outcome of this 
enquiry as significant for policy development, particularly as related to this case 
study. Firstly, it found that hypertension was the leading cause of maternal mortality 
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(prior to the escalation in AIDS related deaths). Secondly, it recommended that a 
national policy be written. In 1998, the national department began drafting the 
'Guidelines for Maternity Care in South Africa'. At the launch of the first report of 
the Confidential Enquiry entitled 'Saving Mothers', members of the College of 
Medicine volunteered to write the management guidelines for the treatment of the ten 
most common causes of maternal death as found through the enquiry. Thus, within a 
year of each other, two national guidelines were published. 
Respondents had varied answers as to why two national guidelines, covering some of 
the same areas and both making explicit use of evidence from systematic reviews and 
randomised controlled trials were written. One respondent suggested that the people 
who wrote 'Saving Mothers' felt the 'Guidelines for Maternity Care' to be a waste of 
time (Acad 4). He suggested that they felt that there was a need to concentrate on the 
common causes of maternal death identified by the first Confidential Enquiry into 
Maternal Death. In this light, the 'Guidelines for Maternity Care' were regarded as 
too broad, 'Saving Mothers' hence attempting to be more specific. Others suggested 
that these two guidelines are aimed at different levels of care. They claim that 
'Saving Mothers' is inclusive of guidelines for care at level 3 (specialist referral) 
institutions, since it was established that maternal mortality was occurring at this level 
too. The 'Guidelines for Maternity Care', according to respondents, are aimed at 
levels 1 and 2. As one respondent explained, there is a shortage of staff at this level, 
particularly a shortage of trained obstetric specialists (DoH 1). These guidelines, she 
suggested, would allow for medical staff, midwives and doctors, not trained as 
specialists, and specialists who had not trained within the country, all to be able to 
deliver the same care that a woman being treated by a specialist would receive. 
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Furthermore, one of the spin offs hoped for in involving academics in the writing and 
reviewing of these guidelines was that they would then take these back to their 
training institutions and begin incorporating it into their teaching. Thus it was hoped, 
that standardisation of care within the country would be achieved. 
But where within this picture did the use of evidence fit in? We knew from our early 
interviews and from our reading of the guidelines that explicit use of evidence had 
been made and thus we questioned respondents as to how this had come about. 
Several interlinked reasons emerge from the data. 
Firstly, respondents repeatedly emphasised that throughout this process the "same 
names" appear. They explained that the academic obstetric fraternity within South 
Africa is small and that members of this fraternity met regularly through the Priorities 
in Peri-Natal Care Conferences, the South African Society of Obstetrics and 
Gynaecology and the College of Medicine. Some respondents felt very positively 
about the influence of this group, others not so, calling them the "big bosses" (Acad 5) 
and an "enfranchised clique" (Acad 8). Whatever their opinion, respondents were 
clear that it was members of this group who had successfully lobbied for the 
conducting of the confidential enquiries into maternal deaths and who then led the 
committee. They also took lead roles in the writing of the 'Guidelines for Maternity 
Care' and similarly for 'Saving Mothers'. Staff appointed to the national department, 
if not leaders within this group, were certainly closely affiliated to it and felt it 
appropriate to draw on their assistance because they knew through association which 
areas members of this group held expertise in. The importance of their influence on 
the use of evidence in the guidelines was that members of this group had been 
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cultured within the philosophy of evidence based medicine and they carried this with 
them into the writing of the guidelines. 
Secondly, as explained by the person who was responsible for writing the first draft of 
the 'Guidelines for Maternity Care', using evidence was not just a reflection of the 
values of the national department, but it was a reflection of the "world that we live 
in": 
"But I mean, in the world we live today, it is the world of evidence based 
practice, evidence based medicine. So one had to be careful about. .. 
cognizant of the fact that one had to use the best available evidence. Because I 
mean, this would be national. .. it would be a reflection of us as a country." 
(DoH 3 p. 11) 
Furthermore, he explains that when he was appointed to start this process he had just 
finished his registrarship and as a consequence of this training, for him, evidence 
based medicine was "the truth I knew, that's how I was cultured." (DoH 3 p. 11) 
Finally and very importantly, as explained by former members of the department of 
health, the use of evidence leant credibility to the guidelines. The department of 
health was attempting to standardise practice through the national guidelines. 
However a perceived challenge to standardisation was the felt tendency of institutions 
to pursue their own identities in terms of treatment protocols. At the same time these 
guidelines needed to be acceptable to a small but highly influential lobby of academic 
obstetricians who were sold on evidence based medicine. In other words, in order to 
get institutions to adopt a national standard, the guidelines would have to be seen to 
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be above questioning, and basing them on credible evidence was seen as a means to 
achieving this: 
"As I indicated, that we want to, the aim of maternal and child health at 
national is to improve the health of women and children, and for anything to 
be used, especially if you include academics and everybody. For anything to 
be utilised, then people want to be convinced that this actually is of benefit and 
it can work. So you then need to have evidence. If you come and say that 
magnesium sulphate works to stop eclampsia and to further prevent people 
from fitting. You see people will say, "where do you get that from", and you 
cannot say, "I heard somebody saying it works". You need evidence, and 
therefore, you have then to rely on the research that has been done. And 
without that information it would be very difficult to convince anybody to 
actually buy into what you are doing." (DoH 1 pp. 6-7) 
"So this (guideline) then starts saying, this is what is accepted as practice in 
South Africa. So that even if you come from Cape Town and you decide 
you're going to give 20 drops, and another one comes from Medunsa and say 
we give 30 drops, then this will say: these are the drops that you must give. So 
that the nurse, who is working with the doctor, knows that this is what has to 
be done. Not to be shouted at because she's running with 25 drops and at 
Medunsa they say "not giving enough", Cape Town says this "you're giving 
more than enough" ... So it is very important then to take the research 
findings and get them into policy. And even get the research to say what is the 
best way ... " (DoH 2 p. 14) 
Evidence then gave power to these guidelines. The authors of the guidelines were 
keenly aware of the social context in which these guidelines were written. They used 
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evidence not only because they believed that it offered the best possible treatment 
solution, but also because they believed that those reading the guidelines would be 
more convinced of the strength of the recommendation if it were supported by 
evidence. These guidelines are a product of their historical era. They reflect the 
values of this era in academic obstetrics. They were written by an authorship cultured 




The data collected for this study has revealed a long tradition of utilisation, production 
and critical reflection on research evidence amongst academic obstetricians in South 
Africa. It also shows that during the time when policies and guidelines for maternal 
health were being written in South Africa, those responsible for these documents were 
open to incorporating research evidence into them. This is reflected in the use of 
evidence in contemporary policies and guidelines. It suggests congruence between 
the opinions of those persons in academic obstetrics and those responsible for policy 
making and guideline development for maternal health. This study shows a positive 
example of research utilisation in policy making and guideline development. 
The literature suggests that although the idea of using evidence to inform policy 
making has come into favour, actualising this idea in practice is complex. In the past 
theoretical approaches and models have been used to understand the process of 
research utilisation. These models evolved from their analysis of research utilisation 
as linear. In the knowledge driven and problem solving models, research is utilised 
because results exist and in addition there is a problem that needs to be addressed 
(Weiss, 1979). With time the complexity captured in these models has increased 
(Kothari et al. , 2005). More recent literature suggests that research utilisation is 
contextually influenced by many factors such as the social and political environment 
in which policy making is taking place (Bowen & Zwi, 2005). The literature suggests 
that research is not always utilised in the same manner, i.e. it can be used in an 
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instrumental, conceptual and symbolic manner (Hanney et al., 2003, Lavis et al., 
2003, Innvaer et al., 2002). Furthermore the literature points out that there are 
different stages in policy making (Bowen & Zwi 2005; Lavis et al., 2002). Research 
can be utilised at any or all of these stages. 
If we look at this study against these arguments, it does not seem at first that a similar 
picture of complexity emerges. Looking at the policy and guideline documents 
outside of the interview data the process appears to be linear. It seems that policy 
makers adopted the most recent evidence available at the stage of guideline 
development. This evidence they used instrumentally in an attempt to solve the 
problem of maternal mortality. Reading these documents alone offers little indication 
as to the possible influence of the social and political context in which they were 
written. But given that the literature continuously suggests that research utilisation 
can be complex, the picture of simplicity emerging from the document analysis 
seemed unusual. Triangulating the data sources however presented a different picture. 
Reading the policy and guideline documents against reflections from the interview 
data suggests that these documents were indeed a product of their time. Applying 
some of the analytical approaches suggested in the literature as different lenses on the 
same data helped to explore this complexity. 
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5.1. Three analytical lenses 
5.1.1. The "Two Communities" Theory 
Let us consider the findings from this study against the "two-communities" theory 
(Innvaer et al., 2002; Kothari 2005; Lavis et al., 2002). Researchers and policy 
makers have been likened to two communities with different perspectives and 
different functions but who are required to understand each other and interact. This 
theory suggests that researchers and policy makers operate separately from each other, 
thus creating challenges for research utilisation. In contrast it has been informally 
suggested that in developing country settings academics are called upon to both 
conduct research and to write policies. This raises questions about the 
appropriateness of the two communities theory for developing countries as 
researchers and academics do not seem to be so separate here. 
Looking at the data generated in this study there appeared to be no clear distinction 
between policy makers and researchers, particularly after the change in government. 
Our respondents suggested that before the change in government, the opportunity for 
engaging policy makers was limited or did not exist. But after the elections in 1994, 
there was a new administration with space in it for new people. At least some of the 
people who were appointed to positions in maternal health were from within the close 
and influential network of academic obstetricians and midwives. When consulting 
outside of government, these new incumbents drew on the assistance of others within 
that circle: - all of them researchers. Furthermore, a fluidity ofroles was observed 
with people moving between academia and government within a short space of time. 
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Thus for example, one of the respondents was initially an academic. He then held a 
key post at the National Department of Health and now again returned to academia. 
This movement was observed in the main study too where several respondents 
followed a similar career path as that described above. In another scenario, 
respondents maintained their academic positions but were often called upon in a 
consultative manner to work with the National Department of Health, serving on 
committees, writing policies and guidelines or offering advice, etc. In this instance it 
would appear that researchers and policy makers were never required to draw closer 
as their close relationships were already formed prior to the consideration of 
developing policies and guidelines, evidence based or not. 
But the closeness between policy makers and researchers observed here, serves to 
hide a deeper level of complexity in the process of research utilisation. The 
committees set up for writing and developing both the "Guidelines for Maternity 
Care" and the "Saving Mothers" guidelines were chaired by academics. In addition 
several of the members of these committees were academics who were also 
responsible for writing chapters of the guidelines. Ifresearchers are writing policies 
and guidelines, then their attitude to research utilisation and the quality of the 
evidence is very important. In this instance it was fortunate that these academics 
shared a belief that policies and guidelines should be evidence based. This could have 
been different, as we cannot assume that all academics share this belief. It suggests 
that advocates hoping to encourage research utilisation in policy need to map out 
carefully who is responsible for writing the policy. Then they need to target their 
marketing appropriately, not just at policy makers or government officials since they 
are only one part of the process along with researchers. This study suggests that the 
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distinction between policy makers and researchers may not be as clear in developing 
countries8 as it can be in more affluent countries. Furthermore, it suggests that 
researchers working close to government are as important to the research utilisation 
process as are government officials and policy makers. 
5.1.2. The Kingdon Framework 
Another useful framework against which to view data from this study is that which is 
suggested by Kingdon (1995). Kingdon's framework is not so much focused on 
policy making as it is on understanding how issues get onto the policy making agenda. 
Key within this framework, is the role of policy entrepreneurs in taking advantage of 
rare windows of opportunity to push their issues onto the policy making agenda. 
These windows of opportunity occur when various streams of activity, namely 
problem solving, policy making and general politics, interact with each other at a 
governmental level. This framework can be used to explain how the need for 
maternal health care policy came to be on the agenda of the National Department of 
Health. 
Prior to the change of government in 1994, little attention was given to maternal 
health at a national level and there were no national policies for this area. This was 
the case despite continuous attempts by advocates, some of whom where respondents 
in this study, to bring the problem of maternal health to the attention of the national 
government. These advocates were also themselves involved in national and 
8 Of course this could be a transient occurrence given that South Africa is in the early stages of its 
democracy, and the capacity of government officials to write policy independently may soon increase 
coupled with the possibility of a decrease in willingness on the part of the administration to directly 
involve researchers. Given that a very different scenario is occurring in terms of the debates and 
controversies around anti-retroviral treatment, this case study may be unique even within this setting. 
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international research networks, which sought to find solutions to the problem of 
maternal health. In other words, they believed that there was a problem; they believed 
that there were potential solutions to this problem and they sought an opportunity to 
bring government attention to this. Using Kingdon's framework (Kingdon, 1995), 
these advocates can be seen to be policy entrepreneurs. 
The political climate however, did not allow these policy entrepreneurs to bring any 
of this to the attention of the national government in a way that would affect 
meaningful change at a policy level. This climate changed dramatically, when in 
1994 South Africa held its first democratic elections and a new national 
administration came into being. Following this change the National Department of 
Health amongst other things employed a new cadre of health officials. Appointed in 
key positions within this process were persons who had strong links to the networks 
of policy entrepreneurs and researchers who sought a change in approach to maternal 
health. These new government employees opened up the space for the policy 
entrepreneurs and researchers to engage with the National Department of Health. As 
a result of the continued advocacy and the new openness, a decision was made to 
conduct a national confidential enquiry into maternal mortality. This enquiry 
established that maternal mortality was a problem and recommended that a national 
policy for maternal health was needed as part of the solution. Only once the need for 
maternal health care policy was expressed did the opportunity for drawing research 
evidence into that policy arise. 
Much of the research utilisation literature is focused on getting research into policy. 
Applying the Kingdon framework (1995) to this data set shows that there may be a 
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prior step. The processes observed here suggest that researchers may need to become 
policy entrepreneurs and point out to government that it needs a policy in the first 
place. What this model does is to show how the development of policy and guidelines 
for maternal health came to be on the agenda of the National Department of Health 
and how policy entrepreneurs were important in this process. It does not explain the 
reason why, when these policies and guidelines were being developed, evidence from 
randomised controlled trials came to be utilised. 
5.2.3. The "three l's" framework 
The 'three I's framework as applied by Lavis et al. (2002) is helpful in illuminating 
the influences on policy making. This framework suggests that in order to 
understand the policy making process at any one moment in time, one needs to take 
into consideration three key influences. It suggests that the process is influenced by 
prevailing ideas ( e.g. values, available information). It is also influenced by those 
people or bodies whose interests are affected by shifts ( or not) in the policy and it is 
influenced by legacies (e.g. a scheduled review of the policy) that inform policy. The 
suggestion of key events as influential (such as major political change) has also been 
proposed. Within this framework all of these influences operate in relation to each 
other. 
One can apply this framework to understanding research utilisation in the Guidelines 
for Maternity Care. As alluded to already twice above, a key event preceding the 
writing of this document was the election in 1994, which brought in a new 
dispensation. Linked to this event the institution of the National Constitution had 
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changed. The constitution of the country now recognised the right to health services 
with attention to the needs of children and women. A prevailing idea at the time was 
that women's health was important. Attending to this need in tum was in the interest 
of the new government in the process ofreforming old structures. Another event, the 
outcome of the findings of the first confidential enquiry, suggested that in order to 
attend to this need, policy making for maternal health was required. An idea held 
very strongly by those persons now charged with the responsibility of writing these 
policies was that policies and guidelines had to be scientifically grounded. They 
believed that policies and guidelines should be based on the best available evidence. 
The best available evidence was believed to be the results from systematic reviews 
and randomised controlled trials. Fortuitously at the time that these ideas were strong 
and the desire for policy was great, a randomised controlled trial showing the 
effectiveness of magnesium sulphate as a treatment was published. Furthermore, 
some of the interests representing the new government felt that this new 
administration needed to be seen to be keeping abreast of the trends. Given the 
strength of the belief in evidence based medicine at the time, using the best available 
evidence was seen to be an expression of keeping abreast in this way. 
Use of this lens gives further suggestion to the idea that the process ofresearch 
utilisation observed in this study was more complex than first meets the eye. There 
were multiple influences on the process of developing the "Guidelines for Maternity 
Care". It was fortuitous that the results from the Collaborative Eclampsia Trial 
(ETCG, 1995) were published only a few years before this guideline was developed. 
However the mere availability of this evidence did not automatically ensure its 
uptake. This framework suggests that this evidence was received in a context which 
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was open to research utilisation, a context which linked best care to best evidence. It 
was published at a time when those developing the policies and guidelines wanted to 
offer the best possible care to women. This framework shows that at the time when 
the "Guidelines for Maternity Care" were being developed all the influences seemed 
to be in agreement with each other. It also shows the interdependency of these 
influences on each other and the precarious nature of the policy and guideline making 
process. If any of these influences had not been in agreement, would the guideline 
have looked similar or even come into existence? We don't know. It does suggest 
that the arguments presented in the literature that context is very important to research 
utilisation are correct. The difficulty for those wishing to influence research 
utilisation is that they may not always have the power or authority to influence this 
context. Coming back to Kingdon (1995) this would suggest that policy entrepreneurs 
need to be vigilant of when the influences are in alignment and when a window of 
opportunity opens so that they can take advantage of the moment. 
5.2. Networks of influence 
In this study a serious attempt was made to find as many respondents as possible who 
had been involved in the policy making and guideline development process and then 
also to find respondents with divergent views. However, it was not that easy to find 
respondents who disagreed absolutely. Instead the interview data suggested that most 
respondents seemed to be in agreement around the concept of evidence and the 
importance of evidence based policies and guidelines9• One respondent (Acad 4), 
suggested that the people in government, those writing the policies and guidelines and 
9 Of the 15 respondents only 2 could be said to have held a different perspective. 
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those in academia all belonged to the same "club". This opinion that policy making 
and guideline development was dominated or strongly influenced by a small but 
strong network of senior academics was shared by several of the respondents (Acad 1, 
Acad 2, Acad 4, Acad 5, Acad 7, Acad 8, DoH 1). As is to be expected some 
respondents were more positive about the influence of this group than others. The 
important issue though, is that this group met regularly through their collaborative 
work, through their various society meeting and through the College of Medicine. 
Influential members of this group were also tied into international networks, which 
strongly promoted evidence based medicine, such as the Cochrane Collaboration and 
the National Perinatal Epidemiology Unit at Oxford. Within this network, the idea of 
evidence based medicine had been well diffused. The opinion that policy making 
should be based on best available research evidence was strongly held. Best evidence 
was understood to be that which was derived from randomised controlled trials and 
systematic reviews. Working together so closely, sharing many of the same ideas and 
having "members" now placed at the National Department of Health, meant that this 
group had a very strong influence over the final policies and guidelines which were 
produced. In this instance the idea of needing to base policy on evidence was clearly 
a strongly held value amongst members of this group. However, the policies (if 
produced at all) could well have been formulated very differently if this group held a 
different set of values. This suggests firstly that networks of influence are very 
important and secondly research utilisation can be unpredictable if dependent on the 
values of these networks. 
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5.3. Building on previous research: Barriers and Facilitators 
Previous research has identified barriers and facilitators to research utilisation 
(Aaserud et al., 2005; Innvaer et al., 2002). This study identified no barriers. 
Facilitators to the uptake of evidence included: 
• The availability and credibility of the evidence from randomised controlled trials. 
• The timeliness of the evidence in relation to policy and guideline development. 
• The close relationship between the policy makers and researchers. 
• A positive attitude towards research utilisation, particularly evidence from 
randomised controlled trials and systematic reviews, in policy making. This was 
shaped by the growth of evidence based medicine and evidence based obstetrics. 
• An amenable or open political context. 
It is important to remember though that both facilitators and barriers are time specific. 
For example, at another moment in time the political context may have been closed 
thus hampering potential research utilisation. Alternatively it may have been open but 
the evidence may not have been available. Relationships can also be fickle. So while 
relationships were good at the time, it could very easily change, especially if the 
evidence suggests something that the policy makers do not like, while the researchers 
are convinced by it. Describing barriers and facilitators is useful but limited. It may 
be more useful to offer a thick description of the full process surrounding the moment 
when research was or could have been utilised. This allows for us to explore the 
process within its full context thus enhancing the possibility that we may learn from 
the experience of others. 
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5.4. Limitations of this study 
This study has adequately covered the research question it set out to answer. There 
are however some limitations. 
The lessons learnt in this study are very useful and the research process and results 
can both be said to be valid and reliable. The depth of the interview process along 
with the depth of analysis and the triangulation with other data sources suggests that 
this study does meet the requirement of presenting "probable truth" (Thorne, 1997). 
However, as this is only one case study, the lessons are very specific and not 
generalisable. The transferability of the insights, which are drawn here, will be 
enhanced when reflected upon in triangulation and in comparison with the insights 
drawn from the other five case studies, which make up the main study. 
One of the objectives of this study has been to develop out of this data set a 
conceptual model of the relationship between research and policy making. This idea 
came from an early reading of the literature, where this kind of modelling was 
attempted in other studies (Kothari et al., 2005). In this study, this has not been 
possible. There were two methodological barriers in this regard. Firstly, the design of 
this study would have had to be far more sophisticated in order to build such a model. 
It would have required that an approach such as grounded theory (Dellve et al., 2002) 
be taken from the outset. In using such an approach the student would have been 
required to pay more attention to the relationship between different issues emerging 
from the data. Instead, this study has taken a very general qualitative approach and 
therefore remains largely descriptive. Secondly, as mentioned above, this is only one 
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case study. Even if a model were developed out ohhis data, it would be an arbitrary 
exercise as the possibility for transferability would be limited. A more credible model 
would build upon patterns observed and compared within more settings and over a 
longer period of time. However, the literature does offer empirically based models 
and an attempt has been made to apply at least some of these models to this data. As 
the discussion tries to show, using these models enhances our understanding of the 
processes. 
A criticism of this study could be that it simply collected and reports on the accounts 
ofrespondents. However, the strength of these accounts is that they are the opinions 
of people who have actually contributed to the formulating of contemporary policies 
and guidelines. Because of their closeness to the process, in reflecting upon their 
accounts and the contradictions between and within them, we are able to reflect on the 
thinking behind the policies and guidelines. In other words we are able to compare 
our document analysis of the policies and guidelines against the policy writers' 
opinions about evidence based guidelines and research utilisation. This data shows 
congruence between what is reflected in the policies and guidelines and the accounts, 
which respondents shared. 
This study has not addressed the issue of implementation. Some respondents 
suggested that this may be a required. Respondents suggested that there may be 
problems at facility level (hospitals and clinics) around availability of the policies and 
guidelines, access to the drug, confusion around whether or not midwives are able to 
administer the drug, etc. However, problems of implementation were never a part of 
the research question. This question remains open for exploration in a further study. 
80 
A further limitation of this study has been that it was difficult in the context of the 
interviews to tease out the difference between respondents' acceptance of the 
evidence for the treatment of eclampsia and their acceptance of the treatment of pre-
eclampsia. Some respondents suggested that the results from the Collaborative 
Eclampsia Trial {ETCG, 1995) were easier to implement than that from the Magpie 
Trial {MTCG, 2002), but in this study that difference was insufficiently explored. We 
suspect that the nature of specific evidence may be of similar importance to research 
utilisation as openness to the use of evidence in general, unfortunately the current data 
set does not allow further exploration of this possibility. 
Although, the data raises many issues around the culture of evidence based medicine, 
in this discussion I have limited my comments to how this affected policy making and 
guideline development. Thus, for example, the fact that some respondents held very 
strongly the view that evidence was important yet at the same time believed that 
evidence was not needed if experience already showed one the "correct" way, is very 
interesting. The phenomenon under investigation however was not the building of an 
evidence based culture, but how different thinking paradigms ultimately influenced 
research utilisation in policy making and guideline development. 
5.5. Implications for research utilisation in policy making 
It is difficult to make recommendations on the basis of this study. However the 
following factors has a positive influence on research utilisation: 
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• The existence of a strong network who held influence over decision making at a 
national level 
• The strongly held belief within this network that policy should be based on 
research evidence 
• The willingness of certain individuals to act as policy entrepreneurs pushing 
forward the need for policy and the need to utilise research in that policy. 
• The readiness of those policy entrepreneurs to take advantage of the window of 
opportunity, which opened with the change of administration. 
• The availability of the evidence from randomised controlled trials at the time of 
writing the policies and guidelines. 
Researchers may not be able to influence events such as a window of opportunity 
opening. However, researchers can ensure that the best evidence is constantly being 
produced and is accessible, they can organise themselves into networks in order to 
enhance their influence, and they can be willing to act as policy entrepreneurs when 
the opportunity arises. 
5.6. Further research 
A key area for further research is that of implementation. This data has shown that if 
the conditions are conducive then the utilisation of evidence from randomised 
controlled trials in policy making is possible. However, what happens after policy 
making? Are these policies being implemented? What influences this 
implementation or not? What are the health systems issues that facilitate or inhibit 
this process? How does the attitude of clinicians, doctors and midwives, interact with 
their willingness to follow these guidelines? To what extent does their sense of 
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agency impact upon this process? These are but some of the questions that could still 
be asked. 
6. Conclusions 
The seeds for evidence use in the recent policies and guidelines were already planted 
in the 1970's. This suggests that changing thinking around policy making and 
research utilisation takes a long time and a lot of work. This has to be done without 
the assurance that that things will change and that the opportunity will arise. It needs 
to be based on the hope of change. The people seeking a treatment solution to 
eclampsia and pre-eclampsia and the proponents of evidence based medicine were not 
assumingly doing so with the idea that South Africa would undergo great political 
change, they were simply working in their streams. We learn from this study that 
policy is indeed politics. The processes observed here suggest that the literature is 
correct in pointing out that an amiable political context is indeed necessary to promote 
the uptake of research information into policy making. 
This case study is a positive example ofresearch utilisation. As has been argued 
through this dissertation, the fact that research had been taken up so easily into policy 
does not imply that the process was not complex. What has been argued is that the 
opportunity to influence policy making can be erratic and out of the researchers' 
control. However, researchers can take on the role of policy entrepreneurs and push 
for their issue to come onto the policy making agenda and push for research to be 
utilised in that policy. The lesson is that when the opportunity arrives the researchers 
need to be ready, the research needs to be available and the researchers need to be 
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willing to engage with the policy making process to ensure that good research is 
appropriately utilised. 
Very little in this study suggests that any of the observed processes were developing 
country specific. The focus however has been exclusively on the policy and guideline 
development stage without exploration of policy and guideline implementation. It is 
likely that the issues of resource limitation which are key to developing country 
settings are more likely to affect whether or not evidence based policies are 
implemented and acted upon than whether the evidence gets into the policy and 
guidelines or not. 
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1.5 Abstract: (120 words maximum) 
Well informed decisions about scaling-up priority services require at least three types of 
information: on local needs and resources (epidemiological and health services data); on the 
relative effects of alternative services; and on local values. This proposal focuses on access 
to and use of the second type of information in scaling-up priority services. It aims to improve 
the uptake by policy makers in low- and middle-income countries of findings from randomized 
controlled trials by describing the barriers and facilitators to the use of such findings. 
Qualitative case studies of two selected health policies will be undertaken in three Southern 
African countries: Mozambique, South Africa and Zimbabwe. The study will contribute to 
ensuring that scaling up utilises evidence based policies and programmes. 
PART II. PROJECT INFORMATION 
2.1 Aim: benefit expected from project for policy process or health system development 
(75 words maximum) 
To improve the uptake by policy makers in low- and middle-income countries of 
find ings from randomized controlled trials (RCTs) by describing the barriers and facilitators to 
the use of such findings. 
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2.2 Objectives: measurable project outputs in a logical, sequential order (220 words 
maximum): 
In three different countries and for two selected health policies: 
i. To describe the formal and informal structures; the political , economic and social 
context; and the processes through which health policy is developed. 
ii. To compare and contrast the demographic, networking and organizational 
characteristics of the key (formal and informal) policy-makers. 
iii. To describe the various interested parties at international, regional , and national level, 
the extent of their influence and their position regarding each policy. 
iv. To explore policy makers' perceptions of what evidence is and the value attributed to 
different kinds of evidence; their knowledge of evidence from RCTs for the selected 
policies ; their accounts of the use of different forms of evidence in policy making; and 
their position (for, against, neutral) regarding the use of evidence from RCTs for policy-
making. 
v. To examine how best to ensure that scaling up is based on pol icies and programmes 
that are evidence-based. 
vi. To report the study findings at national , regional and international fora and in various 
journals and publications. 
2.3 Background and justification 
2.3.1 Health problems addressed and their ranking within national health priorities 
(180 words maximum): 
This project addresses the translation of evidence from RCTs into health policy making. This 
will be explored through case studies of policies for two important health interventions: 
magnesium sulphate (MgS04) for the control of preclampsia/eclampsia among pregnant 
women and insecticide impregnated bed-nets for malaria control. 
Case study 1 : 
Pre-eclampsia and eclampsia are important contributors to maternal and 
infant morbidity and mortality in low-income countries (WHO 1988). Strong 
evidence is available of the effectiveness of MgS04 for women with 
eclampsia and pre-eclampsia (Eclampsia Trial 1995; Duley 2003a; Duley 
2003b; Magpie Trial 2002; Duley 2003c). However, there is concern that this 
safe, inexpensive drug may still not be available in many countries 
(Magnesium 2002; Mahomed 1998). Many women could benefit from these 
RCT results, provided they are scaled up into appropriate policies and 
actions. 
Case study 2: 
Malaria remains a major contributor to the burden of disease in low-income 
countries (WHO 2002). Trials have demonstrated the effectiveness of 
insecticide-impregnated bednets in reducing malaria incidence in endemic 
regions (Lengeler 2003). However, there are still controversies regarding the 
sustainability of bednet programmes and their relative effectiveness compared 
to traditional household spraying with insecticides (Curtis 2000; Lengeler 
2001; Curtis 2001). Decision-makers need to assess these uncertainties in 




2.3.2 Current structure and situation of the health system (270 words maximum): 
Mozambique: Mozambique has a National Health Service based on the 
primary health care approach. This service provides the bulk of health care, 
although the numbers of both private providers and non-governmental 
organizations are increasing. The Ministry of Health produces a national 
formulary and an essential drugs list and determines which medicines are 
included in them. Within the Ministry of Health, the Departments of 
Reproductive Health Epidemic and Endemic Diseases make policy on use of 
antenatal/obstetric care and malaria control , respectively. 
South Africa: South Africa has extensive public and private health systems. 
Public sector primary care is free and most antenatal care and malaria 
treatment are delivered within the public sector system. National guidelines for 
the treatment of eclampsia and pre-eclampsia have been formulated (DOH 
1998; DOH 2003) and include the use of MgS04. MgS04 is widely available 
and previous studies suggest that it is used extensively for treating eclampsia 
but less extensively for pre-eclampsia (Aaserud 2003 - see abstract in section 
2.10). National guidelines for malaria prevention recommend the use of both 
insecticide treated bednets and household spraying. 
Zimbabwe: Zimbabwe has a national health system based on the primary 
health care approach. Over 90% of care is provided by government services 
and the missions, with the private-for-profit sector serving 8% of the 
population. The Ministry of Health and Child Welfare (MoHCW) produces a 
national formulary and an essential drugs list for public sector facilities. There 
is a long history of effective household spraying for malaria control, though 
recently insecticide-impregnated bed-nets have been piloted. MgS04 is not 
used in public facilities for the management of eclampsia/pre-eclampsia, and 
in recent years, its availability has decreased. The MoHCW Planning Pool , 
(consisting of all department heads) is responsible for policy development. 
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2.3.3 Scaling-up or health system integration issues /problems addressed (400 words 
maximum): 
Effective and affordable interventions are available for many of the health 
problems contributing to the burden of disease in low- and middle-income 
countries (WHO 2002). However, these interventions are often not 
implemented at national level, or are discarded in favour of unproven 
interventions. For example, research has indicated that in many settings 
MgS04 is not recommended or available for the treatment of eclampsia and 
pre-eclampsia, despite strong evidence for its effectiveness (Aaserud 2003). 
This problem occurs even within the countries that generated the evidence of 
effectiveness. Good evidence of effectiveness from local or international 
studies is therefore not necessarily or consistently scaled up to national level 
or implemented as national policy. National policies promoting ineffective 
interventions are an inefficient use of scarce resources and may do harm. 
In other circumstances, clear evidence is not available on the most effective 
and appropriate interventions to address a health problem. For example, 
insecticide impregnated bednets have been shown to be effective in 
experimental conditions but there are still questions regarding the 
sustainability of this intervention in low income communities, particularly if 
individual households have responsibility for maintaining nets and purchasing 
insecticide. Furthermore, debate continues on the relative effectiveness of 
treated bednets and house spraying with insecticide (Curtis 2000; Lengeler 
2001; Curtis 2001). In these circumstances, the scaling up of interventions 
may be more problematic and policy makers may need to take judgements on 
the applicability of the evidence to particular settings. How policy makers 
weigh different types of evidence in making such decisions is not clearly 
understood. 
Well informed decisions about scaling-up priority services require at least 
three types of information: information about local needs and resources 
(epidemiological and health services data); information about the relative 
effects of alternative services; and information about local values. This 
proposal focuses on access to and use of the second type of information in 
scaling-up priority services. Maternal child health and malaria are priority 
problems in all three countries. There is a significant avoidable disease 
burden from malaria and eclampsia, in part because the results of rigorous 
evaluations of the effects of interventions to address these problems have not 
been used to inform policy decisions. The gap between the production of 
rigorous evidence and development and implementation of evidence based 
policies is therefore a key factor in the pathway towards scaling up research 
findings and interventions. 
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2.3.4 Policy/health system actors and processes to be addressed by the project (330 
words maximum): 
There are two groups of actors who are key to addressing the gap 
between the production of evidence and its uptake into policies in low- and 
middle-income countries: policy makers at regional and national levels and 
researchers. This study plans to focus on the first group and will explore the 
barriers and facilitators experienced by policy makers to the uptake of findings 
from RCTs. Understanding these barriers and facilitators experienced by 
policy makers will, we anticipate, facilitate the development of interventions to 
increase the uptake of RCT evidence into policy making at national and 
regional levels. These interventions might include training or materials for 
policy makers. Such interventions contribute to ensuring that scaling up is 
based on policies and programmes that are evidence based. A model for this 
process can be found in the extensive body of research on the promotion of 
evidence-based clinical practice. This research has explored the barriers to 
implementation and tested a range of interventions such as academic 
detailing; training; and audit and feedback (Grimshaw 2001). 
The complexity of the policy making environment, in terms of actors, content, 
context and process (Walt 1994a), suggests, firstly, that the development of 
interventions at this level will be a considerable challenge and, secondly, that 
the interventions are themselves likely to be complex and multi-faceted 
(Campbell 2000; lnnvaer 2002). Because policy making is a profoundly 
political process, the case studies will locate the use of evidence within the 
political, economic and social contexts in which policy making occurs and 
explore the processes through which policy making occurs. 
In each of the three case study settings (Mozambique, South Africa, 
Zimbabwe), the research teams are already working closely with national and 
regional departments of health. This should facilitate access to policy makers 
as well as subsequent uptake of the study findinQs. 
2.3.5 Expected benefits of research project for policy/health system development (120 
words maximum): 
This research will have important benefits for policy development 
because it is about policy making, and how to ensure that scaling up is based 
on policies and programmes that are evidence based. More evidence-based 
policies will contribute to health system development by reducing the 
inefficient use of resources on ineffective interventions. These resources may 
then be available for interventions that have been shown to impact positively 
on service delivery and on health and well-being. The research process itself 
and the dissemination of the findings may draw the attention of policy makers 
to the important role of evidence in policy making. The study will also 




2.4 Conceptual framework and bibliographic review (580 words 
maximum) 
Low and middle-income countries are faced with a number of difficulties in providing 
equitable, appropriate and accessible health care. One of these challenges is reconciling 
health needs with available resources. Interventions of proven effectiveness and affordability 
need to be identified, piloted and scaled up to national level. 
There is a growing body of evidence on interventions that are efficacious, affordable and 
appropriate (Cochrane Library 2003; WHO 2002). Nonetheless, these interventions are often 
not implemented or scaled up. It is not clear what factors affect the uptake of evidence 
regarding the effectiveness of interventions into policy making. A recently completed 
systematic review (lnnvaer 2002) and case study (Aaserud 2003) showed the following : 
• There is only limited evidence supporting the many views in the literature on how policy 
makers use research evidence. Barriers and facilitators of the use of research evidence 
in policies are still poorly understood. This is a particular problem with regard to the 
uptake of evidence from RCTs into policy making in low- and middle-income countries. 
Only 4 of 24 eligible studies in the review were conducted in such settings (also see 
Garner 1998). 
• The relationships between the production of evidence and the development and 
implementation of evidence-based policies are complex, variable and poorly understood. 
It is therefore not clear how best to ensure that priority health problems are addressed in 
an evidence-based way when programmes are scaled up to national level. 
A related question is what constitutes 'evidence' in the eyes of policy makers? 
This may include findings from RCTs as well a wide range of other 'evidence', 
including the views of important stakeholders (Rosen 2000). Further 
investigation is needed of how these different forms of evidence are utilised, 
both directly and indirectly (Elliott 2000), in policy making. 
To address these questions, this study will explore the factors affecting the 
uptake of evidence into policies. A case-study approach will be used. Rather 
than testing any one of the large number of policy making theories (Walt 
1994b; Sutton 1999), this study will use an inductive approach and will draw 
on the data collected to develop an understanding of how evidence is used in 
policy making. The model derived from this process will then be related to 
relevant theories. 
Policy making for two different types of intervention will be examined: 
community-based (bed-nets as against insecticide spraying), compared with 
hospital (magnesium sulphate). These cases also represent two different 
priority health areas: reproductive health and infectious diseases. Studying 
two different conditions from different areas will allow for important differences 
in evidence use to be elucidated. The case studies will be drawn from three 
countries: Mozambique, South Africa and Zimbabwe. Although there are 
some similarities between countries, there are differences in health systems 
and resources; in current and past policies with regard to malaria control and 
the treatment of preclampsia/eclampsia; and in their relationships to national 
and international policy networks. Including three countries will help to 
illuminate the similarities and differences in policy making across different 
settings, thereby improving the generalisability of the study findings. 
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We have focused in particular on the use of evidence from RCTs as these are 
widely accepted as producing the most robust evidence of the effectiveness of 
health care interventions. However, we acknowledge that RCTs are not 
always feasible and that, in some instances, observational studies may 
provide better evidence. Moreover, the results of randomized trials may not 
always be applicable, if for example, the participants are highly selected and 
motivated relative to the population of interest. Hence this study looks at the 
range of evidence used by policy makers in their decision making. 
2.5 Project design and methods 
2.5.1 Research questions and/or hypotheses (240 words maximum): 
Main research question: What are the barriers and facilitators to the use of 
findings from RCTs by policy makers in low- and middle-income countries? 
Specific sub-questions: 
1. What are the formal and informal structures and the processes through 
which health policy is developed in each setting? 
2. What are the political , economic and social contexts in which policies are 
being made? 
3. What are the demographic, networking and organizational characteristics 
of the key (formal and informal) policy-makers? 
4. How do policy makers perceive 'evidence' and what values do they 
attribute to different kinds of evidence? 
5. What is policy makers' knowledge of evidence from RCTs for the selected 
interventions? 
6. How do policy makers use different forms of evidence in policy making? 
7. What are policy makers' views regarding the use of evidence from RCTs 
for policy-making? 
8. How do other stakeholders at international , regional , and national level 
influence policy making for the selected interventions? 
9. How can it be ensured that scaling up is based on policies and 
programmes that are evidence-based? 
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2.5.2 Population and/or actors to be studied (260 words maximum): 
Health policy makers: 
• The study will focus on national level policy makers (Ministry of Health) in 3 
countries (Mozambique, South Africa and Zimbabwe) as well as selected 
provincial policy makers in South Africa. 
• Policy makers will be selected on the basis of being currently, or in the 
recent past, involved in developing policies, firstly, for the use of magnesium 
sulphate for the control of pre-eclampsia / eclampsia and, secondly, for the 
control of malaria using insecticide impregnated bednets and / or household 
insecticide spraying. The informants need to be of sufficient seniority to be 
able to take policy decisions, for example on programme specifications. 
These individuals will generally be Directors or Deputy-directors of units in 
the ministries of health. The majority can be expected to be health 
professionals. 
Other policy actors: 
• We will also include informants from relevant non-governmental, 
international and regional organisations operating in the three study 
countries. 
• The informants will be selected on the basis of having been directly or 
indirectly involved in policy development for the case study policies. Direct 
involvement might include participation on a committee developing 
management guidelines or the provision of advice directly to the primary 
policy makers. Indirect involvement might include formal or informal lobbying 
of policy makers regarding policy decisions or the submission of materials to 
inform policy making on a particular topic. 
As we will be using a qualitative approach, it is not possible to indicate in 
advance precisely the number of actors that will be included (see section 
2.5.5). Data collection will rather continue until theoretical saturation is reached 
(Brewer 2000). 
2.5.3 Key variables and indicators (260 words maximum): 







Structures, context and processes of health policy 
described bv month 3. 
Characteristics of key policy makers compared by 
month 6. 
Policy actors at various levels described by month 
7. 
Use of evidence in policy making explored by month 
8. 
Objective 5 Implications for scalinQ up examined bv month 8. 
Objective 6 Studv findinQs reported in various fora bv month 12. 
* Please note that it is not possible to identify dependent and independent 
variables for qualitative research. Verifiable indicators of project progress have 
therefore been listed here. 
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2.5.4 Bibliographic and documentary research strategy (150 words maximum): 
A literature review will be conducted of the factors associated with the 
uptake of research findings into policy. This will complement and update an 
existing systematic review on health policy-makers perceptions of their use of 
evidence in which one of the research team was involved (lnnvaer 2002). This 
review included studies published up to June 2000. 
Search strategy: 
Using combinations of index terms and text words developed for the earlier 
review, we will search the following databases from July 2000 to December 
2003: Medline, EMBASE, International Bibliography of the Social Sciences; 
Psyclnfo; ISi Web of Science; United Kingdom NHS National Research 
Register; and the International Political Science Abstracts. 
Selection criteria: 
We will include interview studies and surveys with health policy decision-
makers regarding their use of research evidence in health policy decisions. 
Studies of clinical decision-making for individual patients will be excluded 
(lnnvaer 2002). Data on the study characteristics, methods used and key 
findings will be extracted from each included study. 
2.5.5 Empirical data sources and observation methods, including sampling and 
measurement techniques (330 words maximum): 
A qualitative case-study methodology is useful to explore this topic given the 
complexity of the issues involved. This approach involves ' .. . the investigation of a relatively 
small number of naturally occurring (rather than researcher-created) cases' (Hammersley 1992 
p185, original italics) . The selected social units (in this instance, a particular policy making 
process) are viewed as a whole, allowing relationships and processes to be examined (Mitchell 
1983). 
The methods will include the following : 
1. A literature review of the factors associated with the uptake of research findings into policy 
(see above) . 
2. A brief document review of the history, structure and processes of policy making for the 
two policies in each country. Relevant documents from regional organizations (e.g. 
SADC) and the WHO will also be examined. 
3. Review of the use of RCT evidence in existing policies on the treatment of pre-eclampsia / 
eclampsia in pregnancy and on the use of bednets I household spraying to prevent 
malaria. 
4. In-depth, semi-structured qualitative interviews with policy makers and other policy actors 
(see section 2.5.2) exploring the following issues: 
the structure and process of policy making 
individual's perceptions of what evidence is; the value attributed to different kinds of 
evidence, and how this has changed over time 
individual's knowledge of evidence related to the selected policies and their accounts 
of the use of this evidence, including evidence from RCTs, in policy making 
factors facilitating/inhibiting the use of data from RCTs to inform policy 
other stakeholders in the policy making process; their position on various policy and 
policy options: the reasons for their position; and the extent of their influence. 
A copy of the draft interview guide is included in section 2.1 O. 
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Informants will be purposively selected to represent the range of policy actors 
identified above. Analysis of data from the early interviews will inform 
subsequent data collection, allowing emerging themes to be further explored 
(Brewer 2000). We estimate that approximately ten to twenty individuals will be 
interviewed in each country. 
2.5.6 Methods to ensure validity and reliability of observations (160 words maximum): 
• An iterative approach to data collection will allow emerging themes to be 
further explored in later interviews. 
• Interviews will be taped, transcribed verbatim and (where necessary) 
translated into English. Interviewers will keep fieldnotes of their thoughts 
and responses during the interview. These will inform data analysis. 
• Systematic and comprehensive analysis of the data will be undertaken. 
• The research team will work collaboratively to develop the coding frame 
(researcher triangulation [Denzin 19891). A sample of transcripts will be 
coded by two researchers to ensure that the coding frame is being 
applied consistently. 
• The constant comparative method, in which the codes emerging from the 
data are constantly compared to new data and thereby refined and 
elaborated, will be used (Brewer 2000). Deviant cases, i.e. informants 
whose opinions are different to the majority, will be examined to ascertain 
the generalisability of the emerging themes. 
• Preliminary findings will be fedback to stakeholders for comment and 
their responses used to inform subsequent work. 
2.5.7 Ethical issues and protections (150 words maximum): 
An application for ethics approval will be submitted to the appropriate Institutional 
Review Board (or Ethics Committee) in each country. Permission to interview Ministry of 
Health staff will be requested from Directors of the appropriate units (e.g. Maternal and Child 
Health; Malaria Programme). 
For in-depth interviews, informed consent will be obtained in writing from each informant. 
Informants will be provided with an information sheet summarising the objectives of the study; 
the purpose of the interview; and their rights as interviewees. They will be assured that non-
participation will not compromise their employment in any way. All informants will be also 
assured of anonymity and confidentiality in the writing of the project report . Pseudonyms or 
generic terms (such as "programme manager") will be used to identify informants in project 
outputs. 
Original interview transcripts will be kept in locked filing cabinets and will be accessible only to 
the research team. 
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2.5.8 Main conceptual challenges in project design/methodology, and expertise 
required to overcome them (180 words maximum): 
Conceptual challenge 
Developing a coherent coding frame 
for qualitative data from multiple 
research settings. 
Developing an understanding of the 
country- and policy-specific 
contextual factors that influence the 
uptake of RCT findings into policy. 
Developing an understanding of 
policy makers' constructions of 
'evidence' and how these 
constructions influence the ways in 
which policies are made and 
implemented. 
Moving from an understanding of the 
barriers and facilitators to using RCT 
evidence in policy making to the 
development of interventions to 
promote evidence based policy 
making. 
2.6 Data analysis methods 
Expertise required 
Analysis of large qualitative datasets 
generated from multiple settings and 
in different languages. 
Policy analysis, particularly in low-
and middle-income settings. 
Familiarity with the sociology of 
science and technology. 
Th is will need to be the subject of 
further studies, but expertise in this 
area would probably add depth to 
this project. 
2.6.1 Processing of data and construction/development of databases (150 words 
maximum): 
All interviews will be audiorecorded and transcribed. This will be done 
by a transcriber employed for this purpose. Approximately 8 hours is required 
to transcribe 1 hour of audiorecording. A sample of transcripts will be checked 
for accuracy against the original audiorecordings. Features in the interview that 
may identify specific individuals will be changed or removed to maintain the 
anonymity of informants. 
The transcripts will then be uploaded into the NUD*IST qualitative analysis 
package in each country. NUD*IST requires a PC with the following 
specifications: 100MHz or better processor; 128 MB RAM; 15MB of free hard 
disk space for installation; a monitor with a minimum 800 x 600 resolution 
(1024 x 768 recommended) ; and a CDROM drive. 
A master file of all transcripts will be held in a secure location by the principal 
investigator. 
.... , ... ·' .~,;.,,·, ..•. ,,.. _,_. ,.· ... - -~-- --~--
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2.6.2 Statistical methods (220 words maximum): 
Not applicable 
2.6.3 Qualitative interpretation methods (200 words maximum): 
Preliminary coding of each transcript will be done in NUD*IST, allowing a database of 
codes and, subsequently, themes, to be developed. Use of NUD*IST will facilitate the sharing 
of coding frames between country teams. Initial data analysis will be undertaken at country 
level, thereby drawing on each country team's familiarity with the local setting. The country 
teams will 'open code' the transcripts by reading through the data and noting ideas about the 
issues raised by informants (Strauss 1990). A coding frame, divided into major themes and 
sub-themes, will then be built. The analysis will focus on identifying key themes and issues 
with regard to the roles of evidence, and particularly evidence from RCTs, in policy making . 
The preliminary coding frames will be circulated between the country teams and a joint coding 
frame then developed during a meeting of the research team. This will facilitate cross-country 
and cross-case comparisons. The interviews will then be re-coded according to this coding 
frame. The themes will later be framed within relevant theoretical perspectives and examined 
in relation to the empirical work of others, as identified in the literature review. In writing up the 
study, the key themes will be illustrated by relevant data extracts. 
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Draft interview guide 
Draft of 27 April 2004 
Introduction: 
Our study is exploring the use of different kinds of information in the process of policy 
making. We are doing this by examining policy making for the treatment and prevention 
of eclampsia and pre-eclampsia and for the use of insecticide treated nets or insecticide 
spraying in the prevention and control of malaria. I am here today to talk to you as 
someone who has experience with the research and policy making for eclampsia and pre-
eclampsia. What we would like to know more about is the factors that led up to this 
policy, and we can go back as far as you like. We are developing a timeline in this 
regard, which I would appreciate your comments on. We would also like to know about 
your specific role in this process and how you understand the role of the other actors. 
Probe: 
role players / interest groups 
significant events I ideas 
significant institutions 
use of different types of evidence 
previous policies 
Questions for ma2:nesium researchers 
Background of respondent 
• Official position 
• Background and training 
What is the current official national policy with regards to the management of 
eclampsia? (What the DoH says clinicians should do). 
What is the current official national policy with regards to the management of 
pre-eclampsia? (What the DoH says clinicians should do). 
[In what way is this different from the provincial policy(ies)?] 
Are there 'unofficial' policies or understandings of how eclampsia should be 
managed? 
Are there 'unofficial' policies or understandings of how pre-eclampsia should 
be managed? 
Would you describe the process by which the policv(ies) was arrived at? 
To what extent were you involved in this process? 
To what extent has your research been used in policy? 
(If they were involved themselves then ask) To what extent have you used 
other people's research in your contribution to the policy making process? 
Introduce the timeline and ask the respondent to comment on it and suggest 
changes/ additions. 
Probe on: 
• When and how the management of eclampsia / pre-eclampsia got on to 
the policy agenda 
• When MgS04 was licensed in the country [For Zim: why not licensed] 




• Eclampsia is always 




• Pre-eclampsia is not 
always treated. 
• Timeline 
• MgS04 has been on 
theWHOEML 
from 1996 
• Whether it is on the essential medicines list for the country and, if so, 
when it was added to the list 
• ' Landmark' events with regard to policies on the management of 
eclampsia / pre-eclampsia e.g. meetings of networks; visits of 
international experts; publication of papers; evaluations 
I would like to talk about the other stakeholders involved in this process of 
policy making with regard to the management of eclampsia and pre-
eclampsia. 
Tell me about the individuals and groups who were particularly influential in 
initiating the process. (Probe international agencies, donors, international 
NGO's as groups). 
What were their specific roles? 
For each, what was the level of influence? How were they able to influence 
the policy process? 
Who has been responsible for formulating or drafting the policies on the 
management of eclampsia / pre-eclampsia? 
What were their specific roles? 
What role if any did you play in this process? 
(probe for networks in which they are / were involved) 
What sort of information or evidence was drawn upon in formulating policy 
on the management of eclampsia / pre-eclampsia? 
How were these different kinds of evidence or information obtained? How 
useful were they? 
Earlier we discussed the different people and groups involved in the process 
of policy making. In what ways were they responsible for providing and 
generating information or evidence? (Probe for use of expert opinion). 
Of the information and evidence gathered, what contribution did evidence 
from randomised control trials and systematic reviews [ or systematic 
summaries] make? 
Could you tell us more about which trials and reviews were referred to and if 
any of these were more or less influential than the rest? 
What factors influenced the use of RCT and systematic review evidence in 
policy making for eclampsia / pre-eclampsia? 
Still staying with our discussion on information, what value would you say 
was placed on these different kinds of evidence or information? Why? 
Was there any process of validating information and evidence from all of the 
different sources? 
How was the strength of evidence for different policy options assessed? 
Were there any differences of opinions I controversies among those drawing 
up these policies? 
How did you decide how to weight these different opinions? 
Were there any uncertainties with regard to the information during policy 
formulation? If so, how were these dealt with? 
Did the way in which evidence was used in this case differ from other policy 
processes in which you have been involved? If so, how? 
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Prompt using timeline 
Have there been any 
shifts over time in the 
types of evidence and 
information used in 
policy making? 
Has the way in which 
evidence and 
information is used 
changed over time? 
How is eclampsia / pre-eclampsia currently treated? 
If a treatment policy is available, how has it been distributed and 
implemented? 
Is there any monitoring of the implementation of the policy / guidelines? 
Who is responsible for monitoring? 
? probe confidence in recollection of the events discussed above 
Suggestions of other policy actors who should be interviewed. 
Suggestions of documents that should be examined. 
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Appendix Three 
Extended Timeline 
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